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Abstract 
 
Major depressive disorder (MDD) is one of the most common mood disorders in the world 
with a life-time prevalence of approximately 17%. MDD is characterized by emotional and 
cognitive disturbances, and is accompanied by volumetric changes of neural areas that likely 
arise from disturbed forms of neuroplasticity. The hippocampus has received a wealth of 
attention in MDD-related research not only because it is a prominent area to study forms of 
neuroplasticity, but also because it is engaged in cognitive as well as in emotional functions. 
In addition, the hippocampus displays a volumetric decrease in MDD. While it has been 
shown that stress associated with the development of MDD modulates forms of synaptic 
plasticity, investigations into the molecular correlates of these plastic changes are negligible. 
The present work investigates the immunolocalization and concentration of synaptic proteins 
involved in synaptic plasticity in the learned helpless model of depression. By means of 
immunogold electron microscopy, the relative concentration of the synaptic proteins 
syntaxin1, the NMDA receptor subunit NR2B, and Arc were examined in different region of 
the synapse. The synaptic regions of interest were the active zone, the postsynaptic density 
(PSD), and the presynaptic and postsynaptic cytoplasm in Schaffer collateral synapses of 
hippocampal area CA1. Comparing the learned helpless group to the wild-type group, I found 
a higher concentration of NR2B in the postsynaptic cytoplasm and in the PSD, as well as a 
higher concentration of Arc in the PSD of the learned helpless group. By contrasting the non-
learned helpless group to the wild-type group, I found a lower concentration of syntaxin1 in 
both the presynaptic cytoplasm and in the PSD, as well as a greater concentration of NR2B in 
the postsynaptic cytoplasm and in the PSD in the non-learned helpless group. In addition, the 
learned helpless group displayed a higher concentration of syntaxin1 in the pre- and 
postsynaptic cytoplasm compared to the non-learned helpless group. The altered relative 
concentrations of these proteins are probably related to changes in synaptic plasticity in the 
learned helpless model of depression. One may speculate that the changed relative 
concentrations of the synaptic proteins contribute to the behavioral changes in the learned 
helpless model, and hence may be related to the pathology of MDD.  
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1. Introduction 
 
1.1 The brain as a substrate for diseases of the mind 
Human beings have a great range of cognitive abilities such as the ability to learn, to make 
decisions or to produce and understand language. All of these functions arise from complex 
communication between cells in the brain. To understand the biological basis of behavior, 
cognition, and emotion, as well as determining the molecular events underlying pathological 
conditions in these human functions is one of today’s greatest scientific challenges. 
Despite the fact that the relationship between rigorous neural activity and the emergence of 
behavior and cognitive states has not been fully understood, the discipline of neuroscience is 
making constant progress in apprehending the working mechanisms of the brain. One of the 
most demanding questions neuroscientists try to find answers to is how consciousness evolves 
in terms of neurobiological processes. The current approach in trying to explain the 
commencement of consciousness focuses on the “neural correlates of consciousness”. These 
neural correlates represent the idea that the firing of neural circuits might eventually terminate 
in conscious awareness. So far, knowledge on the neural mechanisms of consciousness is 
sparse (Chalmers, 1995).  
Much of our current understanding of the brain derives from Santiago Ramon y Cayal’s 
neuroanatomical investigations of the nervous system which lead to the foundation of the 
neuron doctrine (Kandel and Squire, 2000). The neuron doctrine postulates that the brain 
consists of a vast amount of discrete cells, the neurons, which pass on information through 
specialized contact points, the synapses. Neurons and synapses are subjected to constant 
experience-dependent modifications throughout life. These changes in neural pathways and 
synapses are the consequence of our daily experiences and shape our future thinking, feeling 
and behavior. Disturbed neural pathways and molecular processes within the synapse might 
lead to the development of psychiatric disease. 
Given the advance of functional neuroanatomy and our increasing understanding of the 
molecular mechanisms underlying synaptic transmission, neuroscience has been contributing 
immensely to neurology and psychiatry. Though there exist many valuable treatment options 
for persons suffering from psychiatric disorders, it is of utmost importance for neuroscientific 
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Figure 1 
12-month prevalence of selected psychiatric disorders by age 
 
Retrieved from “Kaplan and Sadock’s comprehensive textbook of psychiatry”, Blazer 
(2000): Mood disorders epidemiology. 
 
 
 
 
 
 
 
 
 
 
 
research to further study neural areas whose activity is affected by psychiatric disorders in 
order to implement excellent treatment options (Kandel and Squire, 2000). 
Understanding the neural mechanism underlying behavior and cognition, and hence 
psychiatric disorders, requires the ever increasing advancement in all fields of neuroscience to 
fully reveal an integrative concept about normal and abnormal human behavior. The purpose 
of this work is to examine the involvement of synaptic proteins in psychiatric disease; in this 
MDD. 
 
1.2 Epidemiology of mood disorders 
Mood disorders, such 
as MDD or substance-
induced mood 
disorders are among the 
most prevalent mental 
disorders in the world 
(figure 1). Furthermore, 
persons affected by 
mental illness show a 
high relapse rate. MDD 
is regarded as one of 
the top ten leading 
medical causes of 
disability in the world, 
being second to only ischaemic heart disease (Murray and Lopez, 1997). The lifetime 
prevalence of MDD of experiencing at least one major depressive episode is 17 %. In 
comparison to all psychiatric disorders captured by the DSM-V (Diagnostic and Statistical 
Manual of Mental Disorders, fifth edition), MDD has the highest projected lifetime risk with 
23 % of the population suffering from MDD by the end of their lives. MDD affects all age 
ranges; however, it affects people above the age of sixty to a lesser extent. While MDD is 
equally affecting males and females during childhood, MDD is more common in women than 
in men after puberty (Seedat et al., 2009, Kessler et al., 2005). About 85 % of recovered 
patients relapse at some time in their lives, and only one out of nine persons that experienced 
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one depressive episode will recover for more than 15 years without any relapse (Mueller et 
al., 1999). 
There are many risk factors associated with the development of MDD. However, it is difficult 
to determine whether these risk factors are an association or causation of MDD. Nevertheless, 
studies have consistently demonstrated that there are four risk factors which are associated 
with MDD. These four risk factors are gender, stressful life events, aversive childhood 
experiences, and certain personality traits (Fava and Kendler, 2000).  
 
1.3 Symptoms and classification of major depressive disorder 
Everybody reacts with sadness in response to a painful stimulus because being sad is an 
evolutionary adaptive response forcing us into action. MDD is not necessarily adaptive and 
distinguishes itself from regular sadness by its severity, pervasiveness, duration, and 
symptoms. These symptoms comprise physiological, behavioural as well as cognitive 
disturbances. A depressive episode is marked in most cases by anhedonia (an inability to 
experience pleasure) and depressed mood (guilt, suicidality etc.). Some patients also 
predominantly express anger or irritability (Hyman and Cohen, 2013). 
The International Classification of Diseases (ICD), 10
th
 edition, chapter V:  Mental and 
Behavioural Disorders by the World Health Organization and the Diagnostic and Statistical 
Manual of Mental Disorders (DSM), fifth edition, issued in May 2013 by the American 
Psychiatric Association are commonly applied diagnostic tools to classify abnormal behaviour 
as manifesting itself in a psychiatric disorder. Though there are different forms of depression, 
MDD is the most common type according to the DSM-V. The equivalent of MDD in the ICD-
10 is recurrent depression. 
As shown in figure 2, the classification of MDD by the DSM-V depends on the expression of 
five or more symptoms that must occur within a two-week period. One of the expressed 
symptoms must be anhedonia or depressed mood. The ICD-10 classifies a recurrent 
depression if one or more depressive episodes occur within a two-week time period, and if the 
patient expresses two out of three core symptoms (depressed mood, loss of interest and 
enjoyment, reduced energy leading to fatigability and diminished activity) and at least three 
common symptoms (Hyman and Cohen, 2013). 
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Figure 2 
Criteria for a major depressive episode 
A. Five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the 
symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Note: Do not include symptoms that are clearly due to a general medical condition, or mood-
incongruent delusions or hallucinations.  
o depressed mood most of the day, nearly every day, as indicated by either subjective report (e.g., feels sad or empty) or observation made by 
others (e.g., appears tearful). Note: In children and adolescents, can be irritable mood. 
o markedly diminished interest or pleasure in all, or almost all, activities most of the day, nearly every day (as indicated by either subjective 
account or observation made by others) 
o significant weight loss when not dieting or weight gain (e.g., a change of more than 5% of body weight in a month), or decrease or increase in 
appetite nearly every day. Note: In children, consider failure to make expected weight gains. 
o insomnia or hypersomnia nearly every day 
o psychomotor agitation or retardation nearly every day (observable by others, not merely subjective feelings of restlessness or being slowed 
down) 
o fatigue or loss of energy nearly every day 
o feelings of worthlessness or excessive or inappropriate guilt (which may be delusional) nearly every day (not merely self-reproach or guilt 
about being sick) 
o diminished ability to think or concentrate, or indecisiveness, nearly every day (either by subjective account or as observed by others) 
o recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a specific plan, or a suicide attempt or a specific plan 
for committing suicide 
B. The symptoms do not meet criteria for a Mixed Episode. 
C. The symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of functioning. 
D. The symptoms are not due to the direct physiological effects of a substance (e.g., a drug of abuse, a medication) or a general medical condition (e.g., hypothyroidism). 
E. The symptoms are not better accounted for by Bereavement, i.e., after the loss of a loved one, the symptoms persist for longer than 2 months or are characterized by 
marked functional impairment, morbid preoccupation with worthlessness, suicidal ideation, psychotic symptoms, or psychomotor retardation. 
Retrieved from http://dsm.psychiatryonline.org/content.aspx?bookid=22&sectionid=1890406#2132 
 
 
 
Because MDD (DSM-V) and recurrent depression (ICD-10) are the major types of 
depression, and are largely overlapping, I will refer to MDD throughout the text when writing 
about depression.  
 
To consider the experimental work in a broader context, I will give a brief overview of the 
anatomy of the nervous system, and will specifically highlight those regions which are 
involved in MDD. 
 
1.4 The structure of the brain 
 
1.4.1 The nervous system and signal transmission 
The nervous system is subdivided into the central nervous system (CNS) and the peripheral 
nervous system (PNS). The CNS comprises the spinal cord and the brain, which is again 
divided into six parts. These six parts are the medulla, the pons and the midbrain (brain stem), 
the cerebellum, the diencephalon (containing e.g. the thalamus and the hypothalamus), and 
the cerebrum (containing the cerebral hemispheres, the hippocampus, structures of the basal 
ganglia, and the amygdala). 
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Figure 3 
Asymmetric and symmetric synapses
 
 
The cerebral hemispheres comprise the largest part of the brain and are divided into four 
different lobes. These are the frontal, the parietal, the temporal and the occipital lobes, each 
embodying a different set of functions such as the planning of actions, somatic sensation, 
vision or hearing. The CNS does not unite with the overlying bone of the skull. Instead, three 
membranes, the dura mater, the arachnoid membrane and the pia mater (collectively called the 
meninges), cover the CNS. The cavernous interior part of the brain, making up the ventricular 
system, is filled with cerebrospinal fluid (CSF). The PNS is defined as all the parts of the 
nervous system lying outside the brain and spinal 
cord, i.e. consisting of the spinal nerves and 
autonomic nervous system (Kandel and Hudspeth, 
2013).  
Brain tissue is made up by two different main cell 
types which are the neurons and neuroglia. A 
neuronal cell consists of a cell body, dendrites, 
axons and synaptic terminals. The intermediate 
filaments, microtubules and actin filaments lend 
the neuron its shape and stability, and are also 
involved in the delivery of pre- and postsynaptic 
supplies to the synaptic plasma membranes. There 
are about 50 different types of neurons each 
expressing different genes and synthesizing 
different proteins (Schwartz et al., 2013). Glia cells 
(astrocytes, oligodendrocytes, ependymal cells and 
microglia) support neuronal functioning. They are 
for example supplying neurons with nutrients and 
oxygen, or are involved in the recycling of 
neurotransmitters. There seems to be evidence that 
astrocytes also regulate synaptic strength and 
synaptogenesis (Nedergaard et al., 2003). 
The contact point for information exchange is at 
chemical and electrical synapses. While in 
electrical synapses electrical current flows 
A = asymmetric synapse in the 
hippocampus. B = symmetric synapse in 
the hippocampus. Arrows point to the 
presynaptic site of the synapse. Compared 
to the symmetric synapse, the excitatory 
asymmetric synapse has a larger synaptic 
cleft, is located on dendritic shafts, and 
expresses a clearly visible PSD. Retrieved 
from 
http://synapses.clm.utexas.edu/anatomy/ch
emical/synapse.stm 
 
A 
B 
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passively through gap junctions, chemical synapses release neurotransmitters which act as 
messengers communicating between the presynaptic and postsynaptic membrane. There are 
two main types of chemical synapses: Excitatory and inhibitory synapses. These two types of 
synapses differ with respect to the kind of postsynaptic response, neurotransmitter types, and 
morphology (figure 3). The more common excitatory type I (asymmetric) synapse has a large 
synaptic cleft, is located on dendritic shafts, expresses a clearly visible PSD, and releases 
glutamate. The inhibitory type II (symmetric) synapse releases GABA (gamma-aminobutyric 
acid) and has a less pronounced, but more elongated, PSD. Though this so-called functional 
Gray concept is accepted and frequently applied, debate continues about the strict division 
between type I and type II synapses (Klemann and Roubos, 2011). 
The information exchange at chemical synapses is mediated by action potentials arriving at 
the presynaptic terminal thereby depolarizing the presynaptic cell. This leads to the opening 
of voltage-gated Ca
2+
 channels. The increasing amount of [Ca
2+
] into the cell triggers the 
actual exocytic fusion of the vesicle membrane with the presynaptic plasma membrane in 
order to deliver neurotransmitters into the synaptic cleft. A coding system of Rab proteins on 
the surface of the vesicle allows for the initial recognition between the vesicle and the target 
membrane. Once the vesicle is tethered to the target plasma membrane by holding onto the 
vesicles’ Rab proteins, v-SNARE’s (SNARE proteins on the vesicle) bind to complementary 
t-SNAREs (SNARE proteins on the target membrane) that ultimately fuse the vesicle to the 
target membrane through an interplay with SM (Sec1/Munc18-like) proteins (Sudhof and 
Rizo, 2011). 
Neurotransmitters are generally divided into amino acids (such as glutamate or GABA), 
amines (acetylcholine, serotonin or dopamine amongst others) and peptides (for instance 
neuropeptides). Released neurotransmitters diffuse from a local high concentration to a region 
with a lower concentration, and in most cases bind to postsynaptic receptors. Whether 
postsynaptic channels open or close depends on the receptor onto which the neurotransmitters 
bind. The opening or closing of channels determines the postsynaptic current generating either 
an excitatory or inhibitory postsynaptic potential in the cell. Neurotransmitters in the synaptic 
cleft are eventually degraded, taken up by astrocytes or recycled and sent back to the 
presynaptic neuron (Bear, 2007). 
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While the section described above focused on the general anatomy and cell biology, specific 
brain regions are involved in MDD. These brains regions, specifically the hippocampus, will 
be highlighted below. 
1.4.2 Brain areas involved in major depressive disorder 
The first serious discussions and analyses of 
the idea that certain neural areas are involved 
in the pathology of mood disorders emerged 
with Papez’s outline of the system of emotion 
(Papez, 1937). This emotion-processing 
circuit involves the cingulate gyrus, the 
hippocampus, the hypothalamus and the 
anterior thalamic nuclei. Today, major parts 
of this system such as the amygdala or the 
hippocampus are accepted structures 
involved in maintaining emotional stability. 
In addition, the PFC (prefrontal cortex) is 
now a recognized neural area of the emotion-
processing system. As discussed below, 
certain neural areas involved in the 
processing of emotion show a volumetric reduction during MDD (table 1). These volumetric 
changes need to be considered with caution. It is not yet apparent whether (i) these volumetric 
changes are sole reversible neuroplastic abnormalities, and (ii) whether structural changes 
precede MDD or occur over the course of the disease. The amygdala, the PFC, and the 
hippocampus have received major attention in neuroplasticity-related research of MDD. 
The amygdala plays a major role in the regulation of emotion due to its involvement in 
emotional learning as well as in coordinating cortical arousal and neuroendocrine responses. It 
is not agreed upon whether the amygdala increases or decreases in size during MDD. It seems 
that in depressed patients the size of the amygdala increases at first, but with iterative 
depressive episodes decreases in size (Hamilton et al., 2008, Lorenzetti et al., 2009). 
The PFC is located in front of the motor and premotor areas and is involved in integrating 
sensorimotor information with motivation and affect. The PFC is grossly divided into the 
Brain region Volume Antidepressant 
treatment 
VMPFC 
 
 
ACC (?) 
 
(Metabolic 
activity) 
Hippocampus 
    
(Volume) 
Amygdala 
(?)   
(Metabolic 
activity) 
DLPFC 
 
(?) 
 
Table 1 
Structural changes in selected brain areas 
ACC = anterior cingulate cortex, DLPFC = 
dorsolateral prefrontal cortex, VMPFC = ventral 
medial prefrontal cortex. Retrieved from Palazidou 
(2012), Br Med Bull. 
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Figure 4 
The hippocampal formation and its internal 
projections 
 
EC = entorhinal cortex, para = parasubiculum, pre 
= presubiculum, DG = dentate gyrus, 
CA1/CA2/CA3 = CA1/CA2/CA3 regions of the 
hippocampus. Retrieved from «The hippocampus 
book», Amaral & Lavenex (2006): Hippocampal 
neuroanatomy. 
dorsolateral prefrontal cortex (DLPFC), the anterior cingulate cortex (ACC), and the 
orbitofrontal cortex. Each of these subdivisions controls different aspects of emotion 
regulation and processing, and shows a varying degree of neural activity during MDD. This 
varying neural activity seems to be correlated with some of the expressed symptoms of 
depressed persons. For example, decreased neural activity in the DLPFC is associated with 
psychomotor retardation and anhedonia. It has been shown that MDD is accompanied with a 
significant decrease in volume of this brain region (Palazidou, 2012). 
The hippocampus proper is part of the 
hippocampal formation (HF) which in addition 
contains the dentate gyrus (DG), the subiculum, 
the presubiculum, the parasubiculum, and the 
entorhinal cortex (EC) as shown in figure 4. 
The hippocomapus is the most widely studied 
brain region in the field of MDD. The reasons 
for this are because i) it is involved in learning 
and memory that play a role in emotional 
responses, ii) it is enriched with corticosteroid 
receptors and a malfunctioning hypothalamic-
pituitary-adrenal (HPA) axis is a prominent 
feature of MDD, iii) it is one of only two brain 
regions known today that exhibit neurogenesis 
which is disturbed during MDD, and iv) it has strong connections with the amygdala and PFC 
(Palazidou, 2012). A hippocampal volume loss is also a distinct feature of MDD (Lorenzetti 
et al., 2009). 
The hippocampus is divided into different parts and structural layers that will be briefly 
outlined in the next section. 
 
1.4.2 CA1 of the hippocampus 
The hippocampus accommodates three distinct regions which are the Cornu Ammonis Area 1 
(CA1), Cornu Ammonis Area 2 (CA2), and Cornu Ammonis Area 3 (CA3) each consisting of 
several layers. 
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Figure 5 
CA1 pyramidal neuron 
 
Pcl = pyramidal cell layer, sl-m = stratum 
lacunosum-moleculare, so = stratum oriens, sr = 
stratum radiatum, Scale bar = 100 µm. Retrieved 
from «The hippocampus book», Amaral & 
Lavenex (2006): Hippocampal neuroanatomy. 
 
Figure 5 displays a CA1 pyramidal cell. The basal dendrites of the pyramidal cells project 
into the stratum oriens. Superior to the pyramidal cell layer in CA3 lays the stratum lucidum. 
Above the stratum lucidum in CA3 and directly above the pyramidal cells layer in CA1 and 
CA2 is the stratum radiatum. The most superficial layer of the hippocampus above the stratum 
radiatum is the lacunosum-moleculare (van Strien et al., 2009). 
During the experimental part of this work I focus 
on the apical dendrites of pyramidal cells which 
span the stratum radiatum of the CA1. 
Irrespective of their location in CA1, all 
pyramidal cells have approximately the same 
dendritic length (13.5 mm). It is known that 
almost 30000 excitatory and 1700 inhibitory 
neurons connect with a single CA1 pyramidal 
cell. Inhibitory input mainly targets the soma and 
the axon of the pyramidal cell. Excitatory input 
arrives through the dendrites of various external 
inputs. The distal tufts of CA1 pyramidal cell 
dendrites receive their main input from the EC 
through the perforant pathway and the thalamus, 
while more proximal dendrites receive the input 
from CA3 neurons through the Schaffer 
collaterals. The analyses of apical dendrites in 
CA1 during this work focus on spines containing 
Schaffer collateral synapses that constitute the postsynaptic sites of excitatory glutamatergic 
input. There are different morphological types of spines in the hippocampus. The morphology 
is possibly related to the spines’ functions such as increasing the surface of dendrites and 
therefore the amount of synapses, restricting and controlling the diffusion of molecules, or 
regulating the electrical cell properties (Spruston, 2008). 
The hippocampus can be regarded as the origin of our knowledge on various types of 
plasticity. Structural and synaptic plasticity have been immensely studied in this neural area 
and revealed many insights on the growth, loss and remodelling of neurons, dendritic spines 
and synapses. It is widely accepted that stress has a negative effect on the rate of neurogenesis 
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or the induction of LTP in the hippocampus. Neuroplastic changes are the consequence of our 
experiences, and are the basis of our future thinking, behaviour, and feeling. Malfunctioning 
forms of plasticity might therefore contribute to the pathology of MDD. Exploring disturbed 
forms of plasticity might reveal explanations why the hippocampus decreases in size during 
MDD. Prominent forms of plasticity will be highlighted below. 
 
1.5 Forms of synaptic plasticity 
Long-term molecular changes of synapses are due to experience-dependent modifications that 
underlie altered neural activity. This process is termed synaptic plasticity. Mechanisms of 
synaptic plasticity are acting at different levels including long-term potentiation (LTP) and 
long-term depression (LTD), as well as structural plasticity or the recently described form of 
homeostatic plasticity. It has recently been shown that plastic changes in the brain as 
measured by region-specific cognitive tasks can be used as a model to test the neuroplasticity 
hypothesis of MDD (Nissen et al., 2010). The neuroplasticity hypothesis assumes that the 
adaptation of neurons and synapses to external and internal stimuli plays a major role in the 
pathology of MDD. The study by Nissen et al. (2010) revealed that synaptic plasticity is 
decreased in the hippocampus and the PFC, and increased in the amygdala as measured by 
cognitive tasks involving one of the later three neural regions. In addition, a study by Hajszan 
et al. (2009) revealed that learned helpless behavior in rats is associated with a loss of 
synapses in the hippocampus. In sum, these studies indicate alterations in long-term synaptic 
plasticity are occurring during MDD. 
1.5.1 Long-term potentiation and long-term depression 
1.5.1.1 Long-term potentiation 
The mechanisms of LTP and LTD demonstrate that individual synapses are capable of long-
lasting experience-dependent modifications. LTP was initially discovered by Timothy Bliss 
and Terje Lømo who found that a high-frequency electrical stimulation (tetanus) of excitatory 
pathways to the hippocampus leads to a long-lasting amplitude increase of the excitatory 
postsynaptic potentials (EPSPs) in dentate granule neurons (Bliss and Collingridge, 1993). 
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Figure 6 
Induction of LTP 
 
During normal synaptic transmission, glutamate (Glu) is released from 
the presynaptic cell and acts on AMPA and NMDA receptors. Na+ flows 
only through the AMPA receptor, because Mg2+ blocks the channel of the 
NMDA receptor. Depolarization of the postsynaptic cell relieves the 
Mg2+ block of the NMDA receptor, allowing Na+ and Ca2+ to flow into 
the dendritic spine. The resultant rise in Ca2+ is the critical trigger of 
LTP. Retrieved from Malenka (1999), Science.  
 
 
 
 
 
Figure 6 shows how LTP is 
induced. The interplay between 
Schaffer collaterals and CA1 
pyramidal neurons relies on 
input-specificity ([Ca
2+
] 
increases only in a certain 
activated dendritic spine) and 
associativity (activation of one 
set of synapses can facilitate 
LTP in another set of synapses 
in the same cell given an 
appropriate time window). The 
release of glutamate from the 
Schaffer collaterals activates 
both AMPARs (α-amino-3-
hydroxy-5-methyl-4-
isoxazolepropanoic acid receptors) and NMDARs (N-Methyl-D-aspartate receptors) in the 
postsynaptic membrane. In contrast to the AMPARs, opening of the NMDARs requires that 
Mg
2+
, which blocks the NMDA channel at the resting stage, is displaced. Removal of the 
Mg
2+
 block is achieved through a concurrent binding of glutamate, and a significant 
depolarization of the postsynaptic cell by means of a Na
+
 influx through the AMPA channel. 
Opening of the NMDARs ultimately allows the conductance of Ca
2+
 into the cell, and 
therefore signals the simultaneous activation of the presynaptic and postsynaptic cell. Due to 
this concurrent activation, NMDARs are said to act as coincidence detectors. The rise of 
[Ca
2+
], the critical trigger of LTP, activates downstream signalling pathways such as the 
protein kinase C (PKC) and calcium calmodulin dependent protein kinase II (CaMKII) (Hu et 
al., 1987). Activation of the kinases leads to an increased effectiveness of the existing 
AMPARs either through enhanced ionic conductance of their channels or by the insertion of 
new AMPARs into the postsynaptic plasma membrane (Song and Huganir, 2002, Bredt and 
Nicoll, 2003). It has also been proposed that retrograde messengers are released in the 
postsynaptic cell, which activate protein kinases in the presynaptic cell leading to an increased 
neurotransmitter release (Malenka and Bear, 2004). 
The development of new synapses during late LTP requires the synthesis of new proteins. 
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This process is mediated by signalling molecules such as PKA (protein kinase A) or CaMKII 
that link the activity of LTP to the nucleus activating transcription factors such as CREB 
(cAMP response element-binding protein) and immediate-early genes (IEG) (Malenka and 
Bear, 2004). The maintenance of LTP eventually leads to structural changes such as an 
increased amount of synapses, growth of dendritic spines, and the remodelling of the 
cytoskeleton (Matsuzaki et al., 2004). 
 
1.5.1.2 Long-term depression 
LTD is induced by prolonged low-frequency stimulation leading to a rise in postsynaptic 
[Ca
2+
]. In contrast to LTP, the lower but longer influx of Ca
2+
 due to the low-frequency 
tetanus leads only to a modest postsynaptic depolarization, and is thus less effective at 
removing the Mg
2+
 blockade of NMDARs. It is assumed that LTD involves the activation of 
NMDARs containing the NR2B subunit (Massey et al., 2004). 
While a high influx of Ca
2+ 
leads to the activation of kinases in LTP, lower but longer influx 
of Ca
2+
 during LTD leads to the activation of the calcium-dependent phosphatase calcineurin 
(CN). This again triggers signalling cascades that activate protein phosphatases 
dephosphorylating the AMPAR subunit GluA1 (Lee et al., 1998) or increased 
phosphorylation of AMPAR subunit GluA2 (Malenka and Bear, 2004). The combinatorial 
effect of the phosphorylation of GluA1 and the dephosphorylation of GluA2 leads to the 
endocytosis of AMPARs in the postsynaptic membrane diminishing the EPSP (Beattie et al., 
2000). Because LTD involves the reduction of AMPARs, place holders, or slot proteins, are 
required to keep signal transmission in balance by substituting the internalized AMPARs. One 
of the slot proteins could be PSD-95. Overexpression of this protein is correlated with a 
reduction of AMPARs while a decrease of PSD-95 is associated with an increased amount of 
AMPARs (Malenka and Bear, 2004). 
Though LTP and LTD are not the only contributors to the development or sustainment of 
volumetric reduction of the neural areas in MDD, there is evidence that these forms of 
synaptic plasticity are involved in MDD. As outlined above, LTP is associated with changes 
in the ultrastructural organization of synapses and spines. Perturbations of LTP in MDD are 
therefore likely to mediate regional volume differences of the brain. For example, rats that 
experienced stress by confining them into restraining tubes showed impaired LTP as 
measured in slices immediately after death (Foy et al., 1987). 
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Figure 7 
Homeostatic synaptic scaling 
 
Unconstrained LTP will lose synapse specificity. Homeostatic 
scaling prevents for instance runaway excitation by reducing the 
strength of other synaptic inputs until the firing rate returns to 
control levels. Retrieved from Turrigiano (2008), Cell. 
 
 
 
 
 
 
The stress-induced negative impact on LTP is modulated by the degree of control the rat 
possesses over the stressor. It has been shown that the rats’ ability to terminate a foot shock 
only diminished LTP slightly, whereas rats who lacked the control to terminate the foot shock 
displayed a significant impairment in the induction of LTP (Shors et al., 1989). This indicates 
that the controllability of aversive stimuli affects synaptic plasticity at the basic level. The 
impairment of LTP is due to the psychological factor of a lack of control and not the shock 
itself. 
It is likely that LTP and LTD are involved in many aspects of the theoretical explanations 
dealing with the pathology of MDD. 
 
1.5.2 Homeostatic plasticity 
Activity-dependent forms of 
plasticity such as LTP and LTD 
tend to destabilize neural network 
activity in the long-run by 
constantly increasing or decreasing 
synaptic strength. Therefore, it has 
been suggested that neurons can 
regulate their activity with respect 
to the global network activity by 
either modulating synaptic activity 
or by changing the properties of ion 
channels (figure 7). This form of 
homeostatic plasticity, or synaptic 
scaling, was initially shown by lowering the inhibition of neurons. At first, inhibition 
increased firing rates of the postsynaptic cell, but later these firing levels fall back to the 
control levels despite not modifying the level of inhibition (Turrigiano et al., 1998). 
It is assumed that neurons have the ability to detect their own firing rates by means of 
calcium-dependent sensors. According to the measured firing rates, the trafficking of 
glutamate receptors leads to a decreased or increased amount of AMPARS and/or NMDARS 
in the postsynaptic membrane (Perez-Otano and Ehlers, 2005). The release probability of 
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Figure 8 
Stages of neurogenesis in the dentate gyrus of the hippocampus 
 
ML = molecular layer, GCL = granule cell layer, SGZ = subgranular 
zone. Retrieved from Mink (2011), Neuron. 
 
 
 
 
neurons demonstrates another homeostatic mechanism, because neurons have the ability to 
release a flexible amount of glutamate thereby regulating postsynaptic activity (Turrigiano, 
2008). 
 
1.5.3 Structural plasticity: Neurogenesis and synaptogenesis 
1.5.3.1 Neurogenesis 
Neurogenesis is the process of generating functional neurons from precursors (Ming and 
Song, 2011). Though it has been thought that this process is restricted to embryonic and 
perinatal stages, there are two “neurogenic” regions, the subgranular zone (SGZ) in the DG 
and the subventricular zone (SVZ) in the lateral ventricles, that generate new neurons 
throughout life. 
Stem cells in the brain are able to perform self-renewal process through cell division and are 
also able to differentiate into specific cell types. One hypothesis assumes that radial glia-like 
cells exhibiting glial fibrillary acidic protein (GFAP) and non-radial cells act as neural stem 
cells leading to the generation of new neurons in the SVZ and the SGZ (Ming and Song, 
2011). 
Neurogenesis largely resembles 
the sequence of generating new 
neurons during development as 
shown in figure 8. For instance, 
radial glia-like cells in the SGZ 
serve as progenitor cells that lead 
to the development of 
neuroblast. These immature 
neurons then migrate into the 
granule cell layer of the DG where they differentiate into granule cells. Within days, dendrites 
of the new neurons develop towards the molecular layer by projecting axons towards the CA3 
(Ming and Song, 2011). The neurotransmitter GABA (Ge et al., 2006) and glutamatergic 
inputs via NMDARs (Tashiro et al., 2006) ensure the survival of new-born neurons. 
During the maturation phase, newly generated neurons display a greater potential of synaptic 
plasticity (Schmidt-Hieber et al., 2004). This might give new-born neurons an advantage in 
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competing with mature neurons. Enhanced synaptic plasticity might also contribute to the 
stabilization of the afferent and efferent synaptic connections. 
In contrast to LTD and LTD, the occurrence of neurogenesis is restricted to only two brain 
regions. A lack of neurogenesis might not be sufficient to describe the broad spectrum of 
volumetric alterations and associated cognitive disturbances as seen during MDD. 
1.5.3.2 Synaptogenesis 
The generation of new neurons during neurogenesis is naturally accompanied by the 
establishment of new synapses between cells. The process of generating new synapses is 
defined as the process involving the formation and precise alignment of a neurotransmitter 
release site in the presynaptic neuron, and a receptive field at the postsynaptic neuron (Jin, 
2005). Synaptogenesis involves two steps. These are the selection of appropriate molecular 
partners to establish synapses in a certain subcellular compartment (synaptic specificity), and 
the process of forming the presynaptic structure and the postsynaptic signaling-rich 
specialization (synaptic assembly) (Colon-Ramos, 2009). 
Synaptogenesis is not restricted to co-occur with neurogenesis. In fact, synapses within neural 
circuits of the cortex are formed or eliminated throughout life due to activity-dependent 
structural changes (Trachtenberg et al., 2002). It has been shown that the generation of spines 
is linked to the generation of synapses a few days after the spines appeared. In addition, these 
new synapses specifically connect with already existing boutons (Knott et al., 2006). As 
measured by in vivo imaging and serial-section electron microscopy (SSEM), 20 % of spines 
in the cortex generally disappear while 60 % of spines persist for a time period of at least 
eight days. The new spines are particularly responsible for the generation of new synapses 
leading to the experience-dependent rewiring of the adult brain (Trachtenberg et al., 2002). 
It has been shown that transient and persistent spines belong to distinct populations (Holtmaat 
et al., 2005). Spines that persisted for more than eight days continued to persist for at least 
three weeks. Transient spines tended to disappear after a few days. In addition, persistent and 
transient spines displayed a different morphology. It might be possible, however, that 
transient spines that contained the developing synapses stabilize at a later stage and then 
enlarge due to synaptic stimulation into persistent spines. 
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The process of turning transient spines into persistent spines might involve the insertion of 
AMPARs into the postsynaptic membrane (Malinow and Malenka, 2002) and LTP 
(Matsuzaki et al., 2004). Interestingly, LTP leads to the generation of thin small spines which 
tend to be transient. These transient spines might grow into larger persistent spines resembling 
the strengthening of synaptic contacts. With respect to MDD, it has been shown that 
inescapable foot shocks in learned helpless rats eliminates synapses in hippocampal area CA1 
and CA3 as well as in the dentate gyrus (Hajszan et al., 2009). In addition, it has been 
proposed that astrocytes regulate synaptogenesis. When neurons are co-cultured with 
astrocytes, the generation of new synapses is increased (Pfrieger and Barres, 1997). 
Therefore, glial cells induce synapses in the CNS and may contribute to synaptic plasticity. 
Taken together, plasticity mechanisms such as LTP and LTD, homeostatic plasticity, and 
structural plasticity are major mechanisms that lead to long-lasting changes in synaptic 
activity. These forms of plasticity are therefore at the heart of the theories that relate MDD to 
plastic changes in the brain. These theories incorporating MDD-associated neuroplastic 
changes of the brain will be outlined in the next section. 
 
 
1.6 Synaptic plasticity in major depressive disorder  
There is strong evidence that uncontrollable aversive life events in human development are 
central to the aetiology of MDD (Pryce et al., 2011). These uncontrollable aversive life events 
most likely correlate with findings of morphological studies showing that MDD is associated 
with alterations in the shape and number of neurons and glia cells (Palazidou, 2012). Though 
there seems to be a strong link between aversive life events and neuroplastic changes leading 
to the onset of MDD, this relationship needs to be considered with caution. First, the exact 
cause-effect needs to be further elucidated, i.e. is a volumetric change of neural areas the 
cause or the result of the pathology of MDD? Second, hippocampal volume loss also occurs 
in other stress related disorders and in schizophrenia (Bremner et al., 1995, Heckers, 2001).  
The volumetric decrease of the hippocampus is crucial to investigate not at least because this 
structure is involved in cognition and emotion regulation – processes that are severely 
disturbed during MDD. The following hypotheses of the development of MDD will focus on 
the structural alterations in the hippocampus. 
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1.6.1 Neurotrophic hypothesis of major depressive disorder 
The hippocampus displays a large potential of plastic modifications and, as outlined above, 
accommodates one of the two neurogenic niches in the brain. Due to the observed volumetric 
change of this neural area during MDD, the neurotrophic hypothesis of depression postulates 
that the cause of neuronal cell loss is the result of a decrease in neurotrophic factors. While it 
was first assumed that neurotrophic factors only regulate cell growth and differentiation of 
cells during development, they are now also known to be involved in plasticity and survival of 
adult neurons. The most prevalent neurotrophic factor is brain-derived neurotrophic factor 
(BDNF) which regulates neurogenesis and synaptic plasticity (Duman and Monteggia, 2006). 
It is claimed that while stress reduces BDNF-mediated signalling, antidepressant treatment 
enhances BDNF-mediated signalling (Krishnan and Nestler, 2008). Malberg et al. (2000) 
highlight that only chronic antidepressant treatment leads to an improvement in mood. This 
suggests that the time interval between the beginning of antidepressant treatment and the 
improvement mood spans the time range of new-born neurons differentiating and maturing 
into functional neurons. So far, however, there has been little discussion about the 
mechanisms by which new neurons enhance mood. Kempermann (2008) proposed that 
neurogenesis increases neural activity allowing the hippocampus to adapt to new experiences. 
The retraction of spines and the decrease in BDNF concentration during stress is mediated by 
an excessive amount of glucocorticoids. Glucocorticoids modulate transcriptional 
mechanisms controlling the concentration of BDNF. Antidepressant treatment increases 
BDNF concentration and the number of spines possibly through the activation of the 
transcriptional factor CREB. These changes might alleviate depressive symptoms by 
preventing actions of stress to influence the hippocampus (Nestler et al., 2002). The 
relationship between the concentration level of BNDF and corticosteroids has been 
demonstrated in a study by Mirescu et al. (2004), who showed that stress in early life 
suppresses neurogenesis later in life. The authors argued that rats separated from their 
mothers develop a hypersensitivity towards glucocorticoids, because they displayed a normal 
level of glucocorticoids but nevertheless display reduced cell proliferation. 
There is also evidence that MDD cannot be attributed solely to a reduction in BDNF 
concentration. In contrast to the hippocampus, the nucleus accumbens (NAc) shows an 
increase of the BDNF concentration level in MDD, and direct infusion of BDNF into the NAc 
leads to depressive behaviour in rats (Krishnan and Nestler, 2008). 
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Overall, the reduced concentration of BDNF and the smaller size of brain regions in stressed 
rats add evidence to the correlation between stress, reduced concentration of growth factors 
and reduced sizes of brain regions. Nevertheless, the effect of other neurotrophic factors, and 
their influence on the development of MDD or antidepressant related changes, need to be 
examined in the future as well. 
 
1.6.2 Monoamine hypothesis of major depressive disorder 
The monoamine hypothesis most likely has been the most prevalent theory of MDD over the 
last decades. Today, the monoamine hypothesis is being regarded as an oversimplified view 
of the pathology of MDD. The popularity of the monoaminergic system in MDD is owed to 
two chemical compounds. These are imipramine and iproniazid, which display antidepressant 
effects by amplifying serotonin and noradrenaline transmission. The monoamine hypothesis 
postulates that a decreased amount of serotonin (5-HT), norepinephrine (NE) and/or 
dopamine (DA) lead to the development of MDD (Krishnan and Nestler, 2008). Today’s 
prescribed antidepressants either inhibit the uptake (e.g. SSRIs, selective serotonin re-uptake 
inhibitors) or inhibit the degradation of monoamines (MAOIs, monoamine oxidase 
inhibitors). 
However, MDD is not solely caused by a decrease in monoamines. Mood conditions in 
patients only improve after several weeks of treatment while, for example SSRIs, lead to an 
immediate extracellular increase in serotonin in the CNS. It is assumed that antidepressants 
enhance functional plasticity such as LTP (Stewart and Reid, 2000). Stewart and Reid (2000) 
have shown that the administration of SSRIs enhances LTP. This was possibly due to the 
generation of new proteins that alter the responsiveness of neurons, or allow the remodelling 
of connections that assist in alleviating depressive behaviour. It could be speculated that this 
enhanced plasticity is might be due to the new-born cells which exhibit a greater potential of 
synaptic plasticity (Schmidt-Hieber et al., 2004). Electron microscopic analyses at the 
ultrastructural level revealed the formation on new synapses during SSRI treatment (Hajszan 
et al., 2009). 
 
1.6.3 Neuroendocrine functions 
The activity of the HPA axis is controlled by many neural pathways. One of them is the input 
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from the hippocampus that inhibits the release of cortisol by the hypothalamic CRF-
containing neurons. It widely accepted that excessive cortisol impairs cell growth and 
enhances cell death during MDD. 
The HPA axis controls reactions to stress through a mechanism which will be briefly outlined 
below. Corticotropin-releasing factor (CRF) is released from the paraventricular nucleus 
(PVN) of the hypothalamus upon inputs from its anatomical connections with the amygdala or 
the hippocampus. This release of CRF initiates the production of adrenocorticotropin (ACTH) 
from the anterior pituitary. ACTH will then enter the bloodstream and reaches the adrenal 
cortex leading to the release of glucocorticoids (cortisol in humans, corticosterone in 
rodents). In chronically depressed patients, the stress hormone cortisol as well as CRF and 
ACTH are elevated due to the absent feedback inhibition of CRF from the hypothalamus. The 
missing feedback inhibition of CRF from the hypothalamus is a result of absent inhibitory 
input from the hippocampus on hypothalamic CRF-containing neurons. Under normal 
conditions, cortisol enhances the inhibition of the hippocampus and may also enhance 
functioning of the hippocampus during cognitive processes. In at least half of the patients 
suffering from MDD, the HPA axis is resistant to the suppression of excess glucocorticoids 
(Palazidou, 2012). It is assumed that a dysregulation of the HPA axis does not provoke 
depressive episodes itself, but rather is the manifestation of neurobiological abnormalities that 
predispose someone to develop MDD (Pariante and Lightman, 2008). 
It has been shown that an increased corticosteroid levels in rats leads to the down-regulation 
of BDNF, and possibly is related to the retraction of spines and cell death (Schaaf et al., 
1998). In addition, it has been shown in rats that stressors in early-life attenuate cell 
proliferation and immature neuron production later in life (Mirescu et al., 2004). The study by 
Mirescu et al. (2004) suggests that aversive experiences in early-life inhibit structural 
plasticity later in life due to a hypersensitivity to corticosteroids. This conceals the possible 
link between stress, a malfunctioning HPA axis and neurogenesis. 
  
1.6.4 Epigenetics 
With a risk of 40-50 % MDD is just as heritable as are other diseases such as type II diabetes 
or hypertension that are generally being considered as genetic diseases (Nestler et al., 2002). 
However, until this point no depression vulnerability genes have been found. It appears that 
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genes alone do not cause MDD but interact with developmental and environmental factors 
leading to depressive behaviour. This relationship between genes and the environment is 
evident due to two reasons. First, the temperament of persons determines which situations 
they place themselves into and second, genetic factors might mediate the stress response of 
individuals towards adverse life events. One finding is that environmental experiences are 
able to change gene functions without changing the DNA sequence, also known as epigenetic 
modifications. Epigenetic modifications such as post-translational modifications of histone N-
terminals or DNA methylation are acquainted through experience in development or might 
also be partly inherited (Krishnan and Nestler, 2008).  
Chromatin of the nucleus is either present as heterochromatin inhibiting the transcription of 
genes or as euchromatin allowing gene expression. Modification of histone proteins, proteins 
of the nucleosome repeat unit of chromatin, enables a mechanism that can switch between 
these two states of chromatin by means of acetylation, methylation or phosphorylation. For 
instance, acetylation of histone acetylases (HAT) opens promotor regions of target genes 
which enables RNA polymerase II to bind, and then increase the transcription rate of, e.g., 
BDNF. On the other side, activation of histone deacetylase (HDAC) leads to a lower 
transcription rate. The modification of histone proteins has been shown to slow down 
neurogenesis in a rat model of social defeat. HDAT inhibitors have an antidepressant effects 
(Paslakis et al., 2011). 
The second form of chromatin modulation, DNA methylation, is regulated by environmental 
influences and has an influence on stress responses. For instance, DNA methylation is 
affected by the maternal treatment in rats. Offspring avoided by their mothers expressed a 
higher rate of anxiety and a lower transcription of glucocorticoid receptors in the 
hippocampus than offspring that received maternal care. The greater concentration of anxiety 
and lower transcription of glucocorticoid receptors is due to the increased methylation of the 
glucocorticoid receptor gene promotor repressing gene expression (Szyf et al., 2005). 
Epigenetics is a relatively new field in depression-related research but there seems to be a 
promising link between environmental factors influencing gene functions, neurogenesis and 
the functioning of the HPA axis. 
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1.6.5 Resilience-related research 
In most cases, people react adversely to painful life events. However, some people do not 
necessarily react with depressive behaviour to situations which seem to be uncontrollable for 
others. Resilience-related research informs us about the two different behavioural responses, 
i.e. whether individuals can adapt well to unfortunate life events or whether they react with 
depressive behaviour (Krishnan and Nestler, 2008). 
It has been shown in an animal model of learned helpless that the level of the transcription 
factor ΔFOSB in substance-P neurons in the periaqueductal gray (PAG) is up-regulated in rats 
that are prone to develop depressive behaviour upon shock stimulation (Krishnan and Nestler, 
2008). Plasticity mechanisms such as LTP and LTD are also differently mediated by stress. 
LTP was significantly more decreased in rats that did not have the ability to terminate an 
inescapable foot shock, i.e. have a lack of control, in the learned helpless paradigm (Shors et 
al., 1989). Furthermore, stressed rats display an increased excitability of dopaminergic 
neurons in the ventral tegmental area (VTA) which release BDNF onto neurons in the NAc. 
Resilient rats on the other side show an up-regulation of potassium channels as a homeostatic 
mechanism to restore normal excitability and low levels of BDNF in the NAc (Krishnan et al., 
2007). 
Though findings are scarce until this moment, it seems that resiliency is an active 
neurobiological process of allostasis that needs to be further explored to advance the 
development of successful treatment strategies against MDD. 
 
1.7 Synaptic proteins involved in major depressive disorder 
It is acknowledged that symptoms of MDD originate from long-term changes in various 
neural areas that mediate cognitive-emotional functioning. Morphological changes affect 
various levels from the ultrastructural level of the synapse to the level of an entire neuron. 
Morphological changes might be associated with the established finding of volumetric 
changes in the neural areas during MDD. The next section of this work will briefly discuss the 
role of synaptic proteins involved in synaptic plasticity. Insights on the involvement of these 
proteins in normal and abnormal brain functioning will inform us how ultrastructural changes 
of the synapse might be related to neuroplastic changes in the brain during MDD. Given that 
previous work in our group has revealed an altered concentration of the proteins syntaxin1, 
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the NMDAR2B subunit and Arc in the whole brain as measured by western-blotting 
(Daaland, 2012), I will pay a particular focus on these proteins. 
 
1.7.1 SNARE proteins 
Short- or long-term changes of neurotransmitter release are the underlying mechanism of 
synaptic plasticity. Synaptic plasticity, or the modification of synaptic strength, can be 
induced through (i) an altered neurotransmitter release presynaptically (including changes in 
the protein network that regulates synaptic vesicle exocytosis and endocytosis controlling the 
release of neurotransmitter), or (ii) changes in the amount of receptors postsynaptically that 
sense the release of neurotransmitters. Some of the core proteins that mediate endocytosis and 
exocytosis are the SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein 
receptor) proteins. 
The SNARE complex includes the fusion proteins of syntaxin1, SNAP-25 (synaptosomal-
associated protein 25) and VAMP2 (vesicle-associated membrane protein 2) which is also 
termed synaptobrevin-2. The SNARE motif of syntaxin interacts with motifs of others 
syntaxins and SNAP-25 thereby shaping the target-membrane SNARE (t-SNARE) complex. 
The t-SNARE complex is located at the target membrane which again interacts with the 
vesicle-membrane SNAREs (v-SNAREs) of the vesicle. The target membrane proteins 
syntaxin and SNAP-25 interact with the vesicle-associated synaptobrevin-2 forming the 
alpha-helical trans-SNARE complex which moves the two membranes together leading the 
opening of the fusion pore and the release of neurotransmitter (Sudhof and Rizo, 2011). 
The focus of this work is on the target membrane protein syntaxin with its distinguished forms 
of syntaxin 1A and syntaxin 1B. In approximately 84 % of the cases the two proteins have the 
same amino acids and interact with the membrane trafficking protein synaptotagmin. Syntaxin 
1A, the first identified syntaxin, is composed of 288 amino acids and is most commonly 
found in neurons and neuroendocrine cells making up approximately 1 % of the total amount 
of brain proteins (Lang and Jahn, 2008). It is assumed that syntaxin1 is primarily expressed in 
excitatory synapses (Koh et al., 1993). Though the common assumption is that SNARE 
proteins are expressed primarily in the presynaptic cell, in particular the active zone, SNARE 
concentration is also found postsynaptically (Jurado et al., 2013; personal communication, 
Suleman Hussain, 2013). For instance, synatxin3 and SNAP-47 are expressed in the 
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postsynaptic cell and are involved in the exocytosis of AMPARs during LTP (Jurado et al., 
2013). 
The involvement of some SNARE proteins in the pathology of a few psychiatric disorders, 
such as schizophrenia is known (Honer et al., 2002). However, the action of these proteins in 
MDD is much less determined. The lack of results is driven by two possible shortcomings in 
the study of SNARE proteins. First, it is problematic to pinpoint whether abnormalities of 
SNARE regulation is a cause or consequence of the given disease. Second, while SNARE 
proteins act cooperatively during neurotransmission, each SNARE protein may play an 
independent role in pathology. For instance, chronic restraint stress leads to an increase of 
VAMP2 in the hippocampus, while there is no difference between chronically stressed and 
non-stressed rats with respect to the concentration of SNAP-25 or syntaxin (Gao et al., 2006). 
On the other hand, Muller et al. (2011) have found that chronic stress down-regulates 
synaptobrevin in the hippocampus, while up-regulating VAMP2 mRNA levels. Furthermore, 
Fatemi et al. (2001) found an up-regulation of SNAP-25 in the presubiculum of depressed 
patients. 
The role of syntaxin1 in the aetiology of MDD is largely unknown, but it seems that syntaxin1 
is up-regulated in the brain of learned helpless rats (Daaland, 2012). Fujiwara et al. (2006) 
investigated the role of syntaxin 1A in knock-out mice and demonstrated that the lack of 
syntaxin 1A significantly impairs LTP. Furthermore, syntaxin 1A KO mice showed an 
enhanced LTP induction by increasing the presence of noradrenaline and dopamine. 
Depletion of these catecholamines reduced LTP. This shows that syntaxin1 might be crucial 
for the exocytosis of dense-core vesicles that regulate the catecholaminergic system. 
 
1.7.2 Glutamate receptors 
It is increasingly acknowledged that glutamate signalling mediated by NMDARs is disrupted 
in MDD and might also be involved in morphological changes of the brain. Glutamate 
receptors exist in two different categories: ligand gated ionotropic receptors and G-protein 
coupled metabotropic receptors. There are three different types of ionotropic glutamate 
receptors, which are AMPA, kainate, and NMDA receptors. While all the ionotropic receptors 
are excitatory, the action of metabotropic receptors can either be excitatory or inhibitory 
(Siegelbaum et al., 2013). 
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The NMDARs contain four subunits of several types (NR1, NR2, NR3, or GluN1, GluN2 and 
GluN3) where for instance the subunit NR2 contains another set of subunits (NR2A, NR2B, 
NR2C, NR2D). One receptor contains two obligatory NR1 subunits and two regulatory 
NR2A-D or NR3A-B units. The combination of subunits determines the function of the 
receptor (Cull-Candy and Leszkiewicz, 2004). NMDARs are able to interact with various 
other proteins initiating intracellular signalling cascades by linking NMDARs to downstream 
signalling molecules, kinases, phosphatases and adhesion proteins. 
The functions of NMDARs are twofold. On the one side, these receptors are crucial for 
excitatory signalling, synaptic transmission and synaptic plasticity. On the other side, chronic 
overstimulation brings about the demise of cells. Ca
2+
 influx is essential for synaptogenesis, 
experience-dependent synaptic remodelling and changes in synaptic efficacy on the basis of 
LTP and LTD. In contrast, an excessive amount of glutamate leads to a great influx of 
deleterious Ca
2+
 into the postsynaptic cell. This high level of Ca
2+
 eventually leads to the 
generation of free radicals that again lead to a retraction of spines (Duman, 2009). Therefore 
NMDARs play an important role in psychiatric disorders with underlying perturbations in 
synaptic plasticity. 
It has been shown that acute stress involving NMDAR activation impairs LTP and enhances 
LTD (Kim et al., 1996). In addition, the concentration of the NMDA subunit NR1 is increased 
(Karolewicz et al., 2009), while the subunit NR2A is decreased in patients of MDD (Beneyto 
et al., 2007, Feyissa et al., 2009). Altering the action of glutamate by means of the NMDAR 
antagonist ketamine leads to antidepressant effects (Zarate et al., 2006). It is believed that 
chronic stress leads to the retraction of spines which is mediated by NMDAR activation, i.e. 
the selective deletion of the NMDARs in the hippocampus does not lead to the retraction of 
spines during stress (Christian et al., 2011). Because the glutamatergic system comprises the 
all excitatory pathways in the brain, variances of this system could be linked to morphological 
changes as seen in the pathology of MDD. 
 
1.7.3 Activity-regulated cytoskeletal gene Arc 
The protein Arc (activity-regulated cytoskeleton-associated protein) is an ideal protein to 
study synaptic changes in MDD. As shown briefly below, this protein is involved in many 
forms of plasticity. In addition, it plays a role in several neurological diseases. However, also 
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the involvement of this protein in MDD has not – according to my best knowledge – been 
explored before. 
Arc, also named Arc/Arg3.1, is an IEG that is rapidly activated upon strong synaptic, 
neurotransmitter or growth factor stimulation and integrates the expression of various genes 
which encode synaptic proteins (Tzingounis and Nicoll, 2006). As revealed by immunogold 
electron microscopy, Arc is mainly present in the PSD of excitatory synapses that recently 
underwent LTP (Moga et al., 2004). The signaling mechanisms of Arc transcription are still 
unknown. It seems that PKA and mitogen-activated protein kinase (MAPK) cascades are 
involved in the induction of Arc (Waltereit et al., 2001). The involvement of Arc in molecular 
aspects of synaptic functions was established when researchers found that Arc regulates 
endophilin 3 and dynamin 2, which are components of the protein network involved in 
endocytosis (Korb and Finkbeiner, 2011). 
As mentioned above, the role of Arc in synaptic plasticity is diverse. First, it has been shown 
that Arc modulates the trafficking and endocytosis of AMPARs (Chowdhury et al., 2006, 
Shepherd and Bear, 2011). Arc either concentrates the endocytic proteins to sites where 
AMPAR endocytosis is possible (Shepherd and Bear, 2011) or it has been suggested that Arc 
indirectly moves AMPARs out of the PSD through an interaction with endophilin and 
dynamin (Chowdhury et al., 2006) thereby mediating forms of plasticity such as LTD (Waung 
et al., 2008). 
Due to its involvement in AMPAR endocytosis it is assumed that Arc has a mediating effect 
on LTP, LTD and homeostatic plasticity. Currently, it is known that Arc has a strong 
influential effect on the late phase of LTP (Guzowski et al., 2000). By applying Arc antisense 
oligonucleotides (AOD) to the dentate gyrus and hippocampal area CA1 the authors were able 
to block the transient increase of Arc mRNA/protein production after high-frequency 
stimulation. The effect of this blockade was not significant during the first 4 hours, but 
decayed LTP to a large extent after 4 hours and decreased to baseline after day five. 
Arc might also be a regulator of homeostatic plasticity fine tuning neuronal activity through 
the endocytosis of AMPARs (Beique et al., 2011). It is accepted that neurons scale up 
AMPARs during low network activity and scale down AMPARs during increased network 
excitability. Similarly, during on-going neural activity AMPARs might be scaled down by an 
increase in Arc and scaled up by a decrease of Arc (Shepherd et al., 2006). 
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Arc additionally modifies cellular responses by controlling the size and type of spines. A high 
concentration of Arc increases the amount of thin plastic spines while it decreases the amount 
of stable stubby spines (Peebles et al., 2010). Notably, LTP increases the amount of thin 
spines which might be related to the increased concentration of Arc (Holtmaat et al., 2005) 
Whether Arc has a direct effect on synaptic plasticity in MDD is unknown. The main finding 
of Arc’s involvement in mood disorders resolves around the fact that the relative 
concentration level of Arc is mediated by antipsychotic drugs, and an up-regulation of Arc in 
the CA1 due to antidepressant treatment might be one mechanism how long-term changes in 
synaptic function are achieved (Pei et al., 2003). Our group has previously found that the 
concentration level of Arc is up-regulated in brains of learned helpless rats (Daaland, 2012). 
 
1.7.4 Other proteins 
Besides the previously mentioned proteins, various other proteins regulating synaptic 
plasticity play a central role in the pathology of MDD. The concentration levels of 
synaptophysin and synaptotagmin, proteins required for the fusion of the vesicle with the 
plasma membrane, are altered after stress exposure. While chronic and acute stress lead to an 
increase in synapotagmin, synaptophysin is significantly decreased (Thome et al., 2001). 
Further support that MDD might have a presynaptic basis and that malfunctioning of 
synaptotagmin correlates with depressive behavior stems from the finding that synaptotagmin 
KO mice show decreased depressive behavior in a forced swim test. The normal behavior in 
synaptotagmin KO mice is expressed instead of an assumed depressive reaction (Ferguson et 
al., 2004). 
The PSD, a dense complex of proteins to assure the presence of sufficient receptors in the 
postsynaptic membrane once neurotransmitters are released from the active zone, is also 
altered upon exposure to stress. Rats implemented with corticosterone pellets have a reduced 
concentration level of the scaffolding protein PSD-95 and the glutamate subunit NR1 in the 
hippocampus. It is assumed that a reduction of PSD-95 leads to a reduction of the insertion of 
NMDARs and therefore leads to spine mortality (Cohen et al., 2011). However, it has also 
been shown that the scaffolding protein PSD-95 is up-regulated in the amygdala of post-
mortem brain of depressed patients (Karolewicz et al., 2009). The same study also found an 
up-regulation of NMDAR2A subunit in the amygdala, suggesting that glutamate signaling in 
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depression is disrupted. In contrast, western-blot analyses revealed that the NMDAR subunits 
NR2A and NR2B, and PSD-95 levels are reduced in the PFC in post-mortem brains of 
depressed patients (Feyissa et al., 2009). 
It has conclusively been shown that genes associated with synaptic functions are down-
regulated during MDD (Kang et al., 2012). The down-regulation of these synapse-related 
genes most likely occurred due to the exposure to chronic unpredictable stress. This down-
regulated might contribute to depressive behaviour. A microarray analysis revealed that the 
mRNA concentration of GATA1, a transcription factor, is increased in the PFC during MDD 
possible leading to the decreased concentration of synapse-related genes and the atrophy of 
dendritic processes. 
Having established a framework of the neuroplasticity hypothesis of depression and possibly 
involved synaptic proteins, I will now turn to the purpose and aim of this project. 
 
1.8 Purpose and aim 
One reoccurring finding is that certain neural areas decrease in volume during MDD. 
Theoretical explanations describing the origins of MDD have shifted in the last decades from 
solely regarding the cause in a deficiency of monoamines to a more complex, and more 
ambiguous, neuroplasticity hypothesis of MDD. The neuroplasticity hypothesis postulates 
that stress alters mechanisms of synaptic plasticity through neuroendocrine, neurotropic and 
epigenetic factors leading to an alteration in the structure and amount of synapses and 
neurons. However, far too little attention has been paid to the molecular correlates of the 
plastic changes in MDD. A way to shed light on possible interactions between forms of 
plasticity, their molecular basis, and how they relate to the pathology of MDD is to explore 
functionally important synaptic proteins involved in synaptic plasticity. The involvement of 
the SNARE protein syntaxin1, the NMDAR subunit NR2B, and Arc in MDD are for the most 
part unknown, or literature has emerged that offers contradictory findings. However, given 
that we know far more about how these proteins act in synaptic plasticity in normal 
conditions, we may be able to describe general synaptic alterations in MDD by gaining 
insights on how these proteins are involved in MDD. Previous studies in our group have 
revealed an increase in the concentration level of syntaxin and Arc, and a decrease in the 
concentration level of NMDARs in the whole brain (Daaland, 2012). 
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In this work, I will compare animals of the learned helpless model of depression to explore 
the relative concentration of the three functionally important synaptic proteins syntaxin 1, the 
NMDAR2B subunit, and Arc by means of their immunoreactivity in Schaffer collateral 
synapses of the stratum radiatum in hippocampal area CA1. In particular, I compare the 
learned helpless group, the non-learned helpless group and the wild-type group with each 
other to detect differences in the synaptic concentration of the proteins of interest. For each 
group, I investigate the proteins of interest using immunogold electron microscopy. Based on 
previous work in our group (Daaland, 2012) and the involvement of these proteins in 
mechanism of synaptic plasticity as outlined above, I propose the following hypotheses that 
will be explored in the remainder of this work: 
 
 
Hypothesis 1: Synaptic concentrations of syntaxin1 in Schaffer collateral synapses in CA1 
are different between the learned helpless, non-learned helpless and wild-type group. 
Hypothesis 2: Synaptic concentrations of the NMDAR subunit NR2B in Schaffer collateral 
synapses in CA1 are different between the learned helpless, non-learned helpless and wild-
type group. 
Hypothesis 3: Synaptic concentrations of Arc in Schaffer collateral synapses in CA1 are 
different between the learned helpless, non-learned helpless and wild-type group. 
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2. Materials and Methods 
 
2.1 Background of the methods 
 
2.1.1 Learned helpless model 
During this work I made use of the learned helpless model of depression. The initial concept 
of learned helpless was put forward by Seligman and Overmier (Overmier and Seligman, 
1967). The concept of learned helpless assumes that misinterpreting cognitive information as 
being more negative than it is will lead to a feeling of helplessness or loss of control. The 
negative interpretation of information and the uncontrollability of aversive events terminate in 
MDD as mentioned above. The learned helpless model is one of the most valid animal models 
of MDD. It displays construct validity (depressive behavior is caused by the same etiologies 
that cause MDD in humans), face validity (profile of symptoms in the model is akin to 
symptoms seen during MDD) and predictive validity (effects of antidepressant treatment is 
similar in the learned helpless model and in MDD) (Vollmayr et al., 2007). 
The use of animal models, specifically related to the validity of those, is associated with 
limitations as outlined in the discussion part of this work. The term model implies that there 
exist deviations from reality. The study of human psychiatric disease can therefore only be 
regarded as an approximation. MDD is a mental disorder that is not defined by the presence or 
absence of only a single feature. Rather, a complex interplay between behavioral, cognitive 
and physiological functions terminates in MDD. 
 
2.1.1.1 Induction of the learned helpless state 
Applying uncontrollable and unpredictable aversive stimuli to a rat induces a depressive 
behavioral state in the learned helpless model. In 10-20 % of the rats, a helpless state is 
induced by applying a foot shock of 0.8-mA for a total time of 40 to 60 min thereby exposing 
the animal to a total of 20 min of electric shock. Following this procedure, the rat is placed in 
the same cage 24 hr later, and is exposed to electric foot shocks. However, this time with the 
possibility to terminate the electric shock by pressing a lever. The degree of failure (i.e. not 
terminating the shock) is related to the degree of helplessness. A rat is being regarded as 
helpless if it fails in about 10 out of 15 cases to press the lever and terminate the foot shock, 
while a failure rate of less than 5 out of 15 the animal is regarded as a non-helpless animal. 
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Applying this criterion, 15-20% of the trained Sprague-Dawley rats are identified as learned 
helpless (Vollmayr and Henn, 2003). 
 
2.1.2 Immunocytochemistry 
In order to detect the antigens of the proteins syntaxin1, NR2B, and Arc I made use of the 
immunolabeling technique. An antibody (or immunoglobulin), which consists of two identical 
heavy chains and two identical light chains forming a Y shape, has an antigen binding sit at 
the tip of the Y where it binds to the antigens of the proteins of interest. However, in order to 
quantify these proteins in the synapse they require an attached molecule which is visible in the 
electron microscope. Therefore, I made use of indirect labeling, i.e. I first incubated the tissue 
in the primary antibody which bound to the antigen of the protein and thereafter incubated the 
tissue in a secondary antibody that binds to the primary antibody (figure 9). In case of 
electron microscopic analyses, the secondary antibody has a gold-tag. The gold particles are 
electron-dense (i.e. reflect the electron beam of the microscope) and therefore visualize the 
original protein in the microscope. 
 
2.1.3 Transmission electron microscopy 
Following the labeling procedure, I investigated the presence of the proteins in synapses with 
the transmission electron microscope (TEM). The TEM offers two advantages in comparison 
to the western-blot technique applied previously (Daaland, 2012) when exploring the relative 
concentration level of proteins. First, this microscopic technique allowed me to identify 
changes at the ultrastructural level of an individual synapse. Second, by using the TEM I 
 Figure 9 
Indirect method for antibody labeling 
 
A tissue antigen (species 1, rat) is exposed to a aprimary antibody (second species, rabbit) that has been made to 
bind the antigen. After binding of the primary antibody, a tagged secondary antibody (third species, goat) is exposed 
to the bound antigen-antibody complex. The secondary antibody was produced to react against all IgGs of the 
second species and contains a tag. The result is a two-layered antibody sequence with an attached tag. Retrieved 
from “Electron Microscopy”, Bozzola & Russell (1992), Immunocytochemistry. 
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could target and visualize specific regions of the brain; in this case the stratum radiatum of 
hippocampal area CA1. 
The make-up of a TEM is similar to a light-microscope with the main difference being the 
illumination source. In case of the TEM, the illumination source is an electron gun with a 
tungsten filament. Once the tungsten filament produces heat, an electron cloud is established 
emitting electrons. The beam of emitted electrons is focused by electromagnetic lenses. 
Depending on how many electrons hit the fluorescent screen, it sends out light that is captured 
by an electronic imaging device such as a CCD (charge-coupled device) camera. The whole 
procedure progresses at high-vacuum because air molecules would interfere with the electrons 
and disturb the image-forming process. While the human eye can resolve between two points 
which are located up to 0.1 mm apart, by use of the TEM points as less as 0.127 nm can be 
distinguished. For biological tissue a maximum resolution of 0.344 nm is excellent as the 
conventionally prepared material does not allow for greater resolution. The magnification of a 
conventional TEM reaches up to 200.000x. At normal conditions, the TEM operates at 100-
120 kV, while 80 kV is seen as appropriate for biological tissue because it gives a better 
contrast than at higher kV (Dykstra and Reuss, 2003). 
 
2.2 Materials 
I obtained sample tissue blocks of a rat inbred helpless line established in the laboratory of 
Prof. F. Henn, Cold Spring Harbor Laboratory, United States. This material contained neural 
tissue of four LH, four NLH rats and two WT rats (appendix 1). As seen in table 2, the 
primary antibodies used for immunolabeling were Anti-Syntaxin 1, 1:30 (AN-002, Alamone 
Labs, Jerusalem, Israel), Anti-NMDAR2B, 1:600 (ab65783, Abcam, Cambridge, UK), and 
Anti-Arc, 1:400 (156003, Synaptic Systems, Göttingen, Germany). Table 3 displays the 
secondary antibody goat anti-rabbit (10nm gold) (ab27234, Abcam, Cambridge, UK) that was 
used in this work. Further information about the solutions described in the following 
paragraphs is depicted in appendix 2 and appendix 3. 
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2.3 Perfusion fixation 
The primary goal of perfusion fixation is to eradicate the tissue of the animal, but at the same 
time preserve the fine structure of the tissue for later electron microscopic analyses. The rats 
were deeply anesthetized with sodium pentobarbital and perfused transcardially with 2 % 
dextran in 0.1 M phosphate buffer (pH 7.4). Thereafter they were fixated with a combination 
of 0.1 % glutaraldehyde (GA) and 4 % paraformaldehyde (PA) in the same buffer. The brains 
were stored in situ at 4°C. 
 
2.4 Region of interest 
The region of interest to quantify the concentration level of the proteins of interest was the 
hippocampal area CA1. Having retrieved the brains from the skull 24 hr after perfusion 
fixation, the brain was sliced until structures of the HF were clearly visible. Thereafter, pieces 
with the size of approximately 1.0x0.5 mm were dissected from the slices of the hippocampus 
 
 Table 3 
Secondary antibodies 
  Goat anti-rabbit IgG H&L 
antibody (Abcam) 
Goat anti-rabbit IgG H&L 
antibody (Abcam) 
Current Lot # GR73433 GR104536-1 
Size 10nm 10nm 
Type Polyclonal Polyclonal 
 
Table 2 
Primary antibodies 
 Anti-Syntaxin1 
(Alomone Labs) 
Anti-NMDAR2B 
(Abcam) 
Anti-Arc (Synaptic 
systems) 
Current Lot # AN-002 GR98904 156003/33 
Host Rabbit Rabbit Rabbit 
Type Polyclonal Polyclonal Polyclonal 
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Figure 9 
Regions of interest 
 
 
 
 
 
 
 
 
 
Figure 9 
Regions of interest 
 
 
Red drawing displays the dissected region of interest, hippocampal area CA1. Bar = 1mm. Retrieved from “The 
hippocampus book”, Amaral & Lavenex  (2006), Hippocampal neuroanatomy. 
 
 
 
 
as shown in figure 9A. Parts of the cortex and dentate gyrus were kept attached to the 
dissected piece for later identification of the striatum radiatum in CA1. 
Immunolabeling was performed on sliced sections of the CA1, and the relative concentration 
levels of the proteins of interest were obtained in selected areas (active zone, PSD, 
presynaptic and postsynaptic cytoplasm) of Schaffer collateral synapses in the stratum 
radiatum (figure 9B). 
 
 
2.5 Tissue preparation 
Once the tissue was dissected, cryofixation was performed in order to stabilize the tissue of 
hippocampal CA1 for later ultramicrotomy and electron-microscopic analyses. One subtype 
of cryofixation is the freeze-substitution method. During this procedure, the biological tissue 
is being frozen and the developing ice crystals are replaced by polymerized resin. 
 
The embedding procedure (freeze-substitution method) was carried out by Bjørg 
Riber, University of Oslo. 
The dissected tissue pieces of the CA1 region were cryoprotected by immersing them in 
increasing concentrations of glycerol (10 %, 20 % and 30 %) buffered in sodium phosphate 
buffer. The tissues were immersed for 30 min in concentrations of 10 % and 20 % of glycerol 
and were immersed overnight in the concentration of 30 % at 4°C. The tissue was then moved 
it into a quick-freeze device filled with propane cooled down with liquid nitrogen to -170°C 
A: Red drawing displays the dissected region of interest, hippocampal area CA1. Scale bar = 1mm. Retrieved from 
“The hippocampus  book”, Amaral & Lavenex (2006), Hippocampal neuroanatomy. B: Schematic drawing 
showing regions of interest (bold) of the synapse in immonogold electron microscopical material of hippocampal 
area CA1. 
 
 
B 
 
A
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in a cryfixation unit (Reichert KF80, Vienna, Austria). 
Afterwards, the tissue was transferred to 1.5 % uranyl acetate diluted in anhydrous methanol 
into the pre-cooled chamber (-90°C overnight). This solution was filled into Reichert capsules 
which were placed in a cryosubstitution unit (AFS, Reichert). Following 30 hr in -90°C, the 
temperature was raised with 4°C increments per hour from -90°C to -45°C. Thereafter, the 
samples were washed with anhydrous methanol to remove water and excess uranyl acetate.  
Once this has been performed, the samples were infiltrated to replace the dehydrated fluid 
with lowicryl HM20 resin (Polysciences, Inc., Warrington, PA 18976. Cat#15924). This 
embedding was carried out at a temperature of -45°C while the tissue was placed in different 
concentrations of lowicryl/methanol. The infiltration lasted for 2 hr at a concentration of 
lowicryl/methanol of 1:1, another subsequent 2 hr at a concentration of 2:1, then 2 hr in pure 
lowicryl and once again overnight in pure lowicryl. The Reichert capsules with the specimen 
were then moved to the lowicryl-filled gelatin capsules in the G-chamber. The capsules were 
transferred to another container filled with ethanol. At last, the resin was polymerized with 
UV-light at -45°C for 24 hr, and then increased the temperature by 5°C increments per hour 
until 0°C was reached. At 0°C the resin was polymerized for further 35 hr. 
 
 
2.6 Ultramicrotomy  
I obtained ultra-thin slices of the embedded tissue block for immunolabeling. At first I rough 
trimmed the 44 blocks (4 blocks per animal) removing abundant plastic, and then fine 
trimmed the blocks to achieve a trapezoid form of 1 mm square at the tip of the block. I then 
cut semi-thin sections (500 nm) with a glass knife where the shorter length of the trapezoid 
was in contact with the glass knife first, i.e. was cut first. The semi-thin sections were 
removed from the water basin of the glass knife and put on a drop of distilled water on a glass 
slide. Once the drops were dried up, the semi-thin sections were stained with toluidine blue 
for 90 sec. After the removal of excess stain, I explored the semi-thin sections as exemplified 
in figure 10 with a light microscope to i) determine the quality of fixation procedure for each 
block, ii) the quality of the tissue section, iii) the clarity of the CA1 and the stratum radiatum, 
and iv) to further trim of excess plastic of the block. Given the criteria a-c, I selected 10 
blocks out of the total 44 blocks (one block per animal). I did not consider blocks of animal 
ID-6006 any further, as these were not well fixated. The semi-thin sections were later used as 
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Figure 10 
Semi-thin section of CA1 
 
The semi-thin (500 nm) section was used to localize the 
stratum radiatum in the ultra-thin (90 nm) section. Pcl = 
pyramidal cell layer, sr = stratum radiatum. 
 
 
 
 
 
 
 
 
 
 
 
Figure 11 
Semi-thin section of CA1 
 
guidance to find the area of the stratum 
radiatum. 
After obtaining semi-thin sections, I cut ultra-
thin sections (90 nm) with an ultratome 
diamond knife (Diatome, ultra 45°) of each 
block. I selected optimal sections free of gaps 
and fractures and placed them on 300 lines 
nickel mesh grids (Electron microscopy 
sciences, G300-Ni) which were mounted with 
a grid coating pen beforehand (Coat-Quick 
“G”). I collected 20 ultra-thin sections of 
each animal (a total of 200 sections). 
 
 
2.7 Immunolabeling 
In order to localize the proteins in the ultra-thin sections with the TEM, I made use of 
postembedding immunogold labeling. In the postembedding procedure, each antigen molecule 
at the surface has the same chance of being immunodetected which is of great importance for 
the quantification of proteins. The relative labeling intensity (number of gold particles/number 
of antigen molecules) is always below 100% in this procedure. The labeling efficacy needs to 
be determined by modifying the labeling protocol for each antibody detecting the protein of 
interest. 
 I followed the postembedding procedure of van Lookeren Campagne et al. (1991) with some 
modifications. Table 4 displays the modified protocol I followed for the various proteins. 
Appendix 4 shows entire protocol by van Lookeren Campagne et al. (1991). 
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All sections were labeled blinded on a grid support plate at room temperature if not otherwise 
specified. First, free aldehyde groups were neutralized by incubating the tissue in TBST (Tris 
buffered saline with Tween 20) buffer containing 50 mM of glycine for 10 min. Afterwards I 
incubated the tissue in TBST containing 2 % human serum albumin (HSA) for 10 min in 
order to block nonspecific antibody binding sites before incubation with the primary antibody. 
In the next step, I incubated the tissue in drops of TBST containing 2 % HSA and the primary 
antibody with respect to its optimal concentration and incubation time as shown in table 4.  
After incubating with the primary antibody, the tissue was rotationally rinsed and immersed in 
TBST, before it was incubated in colloidal gold-secondary antibody for 90 min. The TBST 
containing the secondary antibody included PEG (polyethelyne glycol-electrolyte) solution to 
avoid clustering of gold particles on the tissue section. After incubation of 90 min in the 
secondary antibody, I rinsed the sections with distilled water and post-stained them with 2 % 
uranyl acetate and 0.3 % lead citrate staining (90 sec each) to enhance tissue contrast. Uranyl 
acetate and lead citrate were removed with distilled water, and sections were left to dry 
completely before use in the electron microscope. 
During the optimization processes in which I determined the correct concentration of 
antibodies and solutions, I applied controls such as leaving out the secondary antibody to 
determine if there exists non-specific binding (negative control), and using an antibody that I 
trust to work to ascertain that the labeling protocol is working properly (positive control). 
 
Table 4 
Protocol immunoincubation 
 Anti-Syntaxin 1 Anti-NMDAR2B Anti-Arc 
Concentration of 
primary antibody 
1:30 1:400 1:600 
Concentration NaCl 0.5% 0.3% 0.3% 
Concentration Triton 0.01% 0.1% 0.1% 
Incubation time primary 
antibody 
30mins in 37.5 degrees 4hrs Overnight 
Secondary antibody 
(10nm) LOT# 
GR73433 GR104536-1 GR104536-1 
Concentration 
secondary antibody 
1:20 1:20 1:20 
Incubation time 
secondary antibody 
90mins 90mins 90mins 
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2.8 Picture acquisition 
I acquired the pictures of Schaffer collateral synapses in the stratum radiatum of the CA1 
using a TEM (Tecnai G
2
 Spirit, TWIN/BioTWIN, FEI Company, Hillsboro, U.S.) operating at 
high tension (80kV) with a magnification of 43 000x. For each group (WT = 2 animals, LH = 
4 animals, NLH = 4 animals) I took a total of 180 pictures (WT N = 180, LH N = 180, NLH N 
= 180) of excitatory synapses. I identified excitatory (asymmetric) synapses by their specific 
morphology. I obtained a total of 540 pictures for each antibody. 
I localized the regions of interests by comparing the structure of the ultra-thin slice under the 
TEM with the outline of the identical semi-thin section under the light microscope. In order to 
avoid collecting the identical synapse twofold and to assure that the pictures were taken from 
a large spread of the given area, pictures were acquired in a top-down/left-right fashion. 
 
 
2.9 Quantification IMGAP and resolution 
Following the acquisition of the pictures, I quantified the gold particles (and therefore the 
relative concentration each protein) of each section with the tailor made program IMGAP 
(IMmumo-Gold-Analysis-Program) (Haug et al., 1994). The regions of interest for 
quantification were the active zone, the PSD, the presynaptic cytoplasm, and the postsynaptic 
cytoplasm. I outlined freehand each region of interest in the cell and gold particles were 
counted either automatically, or manually in case a type-I or type-II error occurred, in the 
regions of interest of each section. 
In order to distinguish the presynaptic and postsynaptic membranes and whether particles 
more likely attach to one membrane or the other, I determined the resolution of the post-
 
 
 
Figure 11 
Two-step postembedding procedure and resolution 
Triangles represent the antigen against which the 
primary antibody (A) was raised. The secondary 
antibody (B) is coupled to a colloidal gold particle (Au). 
The radius (r) of the gold particle is 5 nm. This adds up 
to a maximum distance of 21 nm between the epitope 
and the centre of the gold particle. Retrieved from 
Mathiisen (2005), Molecules, neurons, systems. 
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embedding technique and adjusted it in the analysis program. As depicted in figure 11, the 
resolution of the post-embedding immunogold technique is theoretically described as the 
distance between the epitope of the antigen and the centre of the gold particle. This equals the 
radius of the gold particle and the total diameter of the antibodies. In practice, however, many 
gold particles are located closer to the epitope of the antigen than as described by the 
theoretical distance (Mathiisen et al., 2005). The resolution (length of antibody bridge and the 
dimension of the colloidal particle) was accounted to be 21 nm (10 nm gold particles with a 
radius of 5 nm, primary and secondary antibody each with a diameter of 8 nm, in sum 21 nm). 
 
 
2.10 Statistical analysis 
I analyzed the data using the statistical software package SPSS (Statistical Product and 
Service Solution) (IBM Corp., Armonk NY). The obtained data of this work are presented as 
mean values with standard errors. A natural log-transformation was applied to non-normal 
data if possible and rendered a good Gaussian distribution. I performed a one-way ANOVA 
(analysis of variance) for independent samples with subsequent multiple comparison post-hoc 
testing for normally distributed data. If the data did not meet the assumption of normality I 
used the non-parametric Kruskal-Wallis test for independent samples, and in case an overall 
effect was found between the groups, I performed subsequent Mann-Whitney U post-hoc 
tests. Though there is no objective way to remove outliers from the data, I removed outliers 
which were further than three interquartile ranges (IQR) away from the end of a boxplot. 
These observations most likely have been caused by chance, or a different mechanism which 
does not reflect the true antigen-antibody binding. While data values being 1.5 IQRs away 
from a boxplot are generally considered as outliers, I kept them in the data, as I had no real 
evidence that these are erroneous values. 
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3. Results 
 
I adopted a criterion for statistical confidence of p < .05. Only the test statistics of significant 
results are reported below. Therefore, not all regions of interest for each protein are 
mentioned. The dependent variables were linear density of gold particles per µm and density 
of gold particles per µm2. The dependent variable linear density (µm) was measured in 
response to the independent variable group belonging (WT=wild-type, LH=learned helpless, 
NLH=non-learned helpless) in the regions interest of the synapse (active zone and PSD) 
(figure 9B). The dependent variable density (µm2) was measured in response to the 
independent variable group belonging (WT, LH, NLH) in the regions interest of the synapse 
(presynaptic cytoplasm and postsynaptic cytoplasm) (figure 9B). If suitable, I applied a log-
transformation in case the assumption of normality was violated. I performed a one-way 
ANOVA for data that followed a good Gaussian distribution. I used the non-parametric 
Kruskal-Wallis test if a transformation was not appropriate for the given data values. I applied 
a Bonferroni adjustment by multiplying the p-value by the number of groups (x3) for all the 
multiple comparisons I performed following an overall effect of the Kruskal-Wallis test. Table 
5 displays a summary of the significant findings between each group. 
 Table 5 
Significant findings of between-group comparisons 
Comparison 
between groups 
Protein Region of 
interest 
Finding Two-tailed p-
value 
LH vs. WT NR2B PostCy LH > WT .012 
 NR2B PSD LH > WT .000 
 Arc PSD LH > WT .048 
NLH vs. WT Syntaxin1 PreCy NLH < WT .002 
 Syntaxin1 PSD NLH < WT .024 
 NR2B PostCy NLH > WT .000 
 NR2B PSD NLH > WT .003 
LH vs. NLH Syntaxin1 PreCy LH > NLH .001 
 Syntaxin1 PostCy LH > NLH .001 
 
LH = learned helpless, NLH = non-learned helpless, WT = wild-type, PreCy = presynaptic cytoplasm, PostCy = 
postsynaptic cytoplasm. 
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3.1 Synaptic concentration of syntaxin1 
I tested the hypothesis that there is a significant difference in the synaptic concentration of 
syntaxin1 in Schaffer collateral synapses in CA1 between the learned helpless, the non-
learned helpless and the wild-type groups. Because the localization of syntaxin1 is likely to 
occur in all regions of the presynaptic and postsynaptic synapse, values of zero, i.e. no 
presence of syntaxin1, were removed from the analysis. 
I was interested in the regions of the synapse beforehand, and therefore I split the file 
according to the region of interest and then compared the groups. The assumptions of the 
ANOVA test, i.e. data values are independent from each other, display homogeneity and are 
normally distributed, were checked. I performed a log (x+1) transformation because a 
Shapiro-Wilk test revealed that the data does not follow normality (p < 0.00). The data 
followed a Gaussian distribution after the transformation. I made use of a one-way ANOVA to 
investigate the concentration of syntaxin1 in various regions of the synapse with respect to the 
dependent variable (linear density µm, density µm2) and the independent variable group 
belonging (WT, LH, NLH). 
3.1.1 Presynaptic and postsynaptic cytoplasm 
An ANOVA with the dependent variable density (µm2) and the independent variable group 
belonging (WT, LH, NLH) revealed an overall effect for the presynaptic cytoplasm (F2,483 = 
7.56, p = 0.001). A Tukey post-hoc test revealed a significant difference between the learned 
helpless and the non-learned helpless group at p < 0.00. The mean of the learned helpless 
group (M = 75.28, SD = 43.21) was significantly greater than that of the non-learned helpless 
group (M = 53.54, SD = 37.77) in the presynaptic cytoplasm. A further Tukey post-hoc test 
revealed an effect for the presynaptic cytoplasm for the wild-type and the non-learned 
helpless group at p = 0.002, where the mean of the wild-type group (M= 65.70, SD=38.85) 
was significantly higher than the mean of the non-learned helpless group (M = 53.54, SD = 
37.77) (figure 12). Syntaxin1 concentration in the presynaptic cytoplasm was therefore greater 
for both the learned helpless group and the wild-type group in comparison to the non-learned 
helpless group. 
Another overall effect of the dependent variable density (µm2) in relation to the independent 
variable group belonging was found for the postsynaptic cytoplasm (F2,483 = 7.56, p = 0.01). 
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As revealed by a Tukey post-hoc test a significant difference existed between the learned 
helpless group and the non-learned helpless group at p < 0.00. The mean of the learned 
helpless group (M = 44.61, SD = 36.80) was significantly greater than for the non-learned 
helpless group (M = 31.45, SD = 24.55) in the postsynaptic cytoplasm (figure 12). The 
concentration of syntaxin1 in the postsynaptic cytoplasm is therefore higher in the learned 
helpless group in contrast to the non-learned helpless group. 
Additional independent t-tests with a Bonferroni correction revealed that syntaxin1 
concentration is higher in the presynaptic cytoplasm compared to the postsynaptic cytoplasm 
within the wild-type (t = 9.55, df = 358, two-tailed p < 0.00), the learned helpless (t = 8.78, df 
= 358, two-tailed p < 0.00) as well as in the non-learned helpless group (t= 7.96, df = 358, 
two-tailed p < 0.00). 
 
3.1.2 PSD 
An ANOVA with the dependent variable linear density (µm) and the independent variable 
group belonging (WT, LH, NLH) revealed an overall effect for the PSD (F2,325 = 3.5, p = 
0.031). Because the one-way ANOVA is an omnibus test and did not reveal between which 
groups the significant differences occurred, a Tukey post-hoc test revealed that syntaxin1 
concentration is significantly lower in the non-learned helpless group compared to the wild-
type group in the PSD at p = 0.024. (figure 13). The mean of the non-learned helpless group 
(M = 9.49, SD = 7.03) was significantly smaller than the mean of the wild-type group (M = 
12.16, SD = 8.60). No significant differences between the groups were found in the active 
zone. Within the groups, there was no significant difference in the concentration of syntaxin1 
between the active and the PSD. 
Though we would expect syntaxin1 to be mainly located presynaptically, compared to the 
non-learned helpless group, syntaxin1 concentration was increased in the learned helpless and 
wild-type group in the pre- and postsynaptic cytoplasm as well as in the PSD and the 
presynaptic cytoplasm respectively. This finding is in line with the assumption that SNARE 
proteins are also active postsynaptically (Jurado et al., 2013; Suleman Hussain, 2013, personal 
communication). 
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A 
Group N Min. Max. Mean Std. 
Dev. 
WT 180 3.82 272.97 65.72 38.85 
LH 180 7.31 207.37 75.28 43.21 
NLH 177 5.70 217.88 53.54 37.80 
 
Group N Min. Max. Mean Std. 
Dev. 
WT 163 2.56 211.48 36.08 29.54 
LH 167 4.43 327.99 44.61 36.79 
NLH 156 3.01 153.00 31.45 24.55 
 
 
 
 
Figure 12 
 
Syntaxin1 concentration is higher in the presynaptic cytoplasm of the LH and WT group compared to the 
NLH group. Syntaxin1 concentration is also significantly higher in the postsynaptic cytoplasm of the LH 
group compared to the NLH group. 
 
Density of syntaxin1 in the presynaptic cytoplasm is significantly greater in the LH compared to the NLH group at p = 
0.001, and in the WT compared to the NLH at p = 0.002. Density of syntaxin1 is also greater in the postsynaptic 
cytoplasm in the LH group compared to the NLH group at p = 0.001. A: Semiquantative analysis of syntaxin1 gold 
particle density in the WT, LH and NLH rats. Bars represent mean value of linear density +/- 2 standard errors of the 
mean of the different groups. B: Electron micrograph from a section of a WT rat showing syntaxin1 immunogold 
labeling of an asymmetric synapse in the stratum radiatum. C: Descriptive statistics of density values in the presynaptic 
cytoplasm of each group. D: Descriptive statistics of density values in the postsynaptic cytoplasm of each group. E: 
Summary of main results. WT=wild-type, LH=learned helpless, NLH=non-learned helpless, AZ=active zone, 
PSD=postsynaptic density, PostCy=postsynaptic cytoplasm, PreCy=presynaptic cytoplasm. Scale bar = 200 nm. Size of 
gold particle = 10 nm. Asterisk=synaptic cleft. 
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Region of 
interest 
Finding Two-tailed p-
value 
PreCy LH > NLH 0.001 
PreCy NLH < WT 0.002 
PostCy LH > NLH 0.001 
 
E 
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   Figure 13 
Syntaxin1 concentration  is significantly lower in the PSD of the NLH group compared to the WT group. 
 
 
 
 
 
A 
Group N Min. Max. Mean Std. 
Dev. 
WT 123 2.27 44.64 12.17 8.60 
LH 119 2.55 47.25 10.73 7.57 
NLH 93 2.89 45.13 9.49 7.03 
 
B 
C 
Linear density of synatxin1 in the PSD is significantly lower in the NLH group compared to the WT group at p = 
0.024. A: Semiquantative analysis of syntaxin1 gold particle density in the WT, LH and NLH rats. Bars represent mean 
value of linear density +/- 2 standard errors of the mean of the different groups. B: Descriptive statistics of linear 
density values of each group. C: Electron micrograph from a section of a WT rat showing syntaxin1 immunogold 
labeling of an asymmetric synapse in the stratum radiatum. D: Summary of main finding. WT=wild-type, LH=learned 
helpless, NLH=non-learned helpless, AZ=active zone, PSD=postsynaptic density. Scale bar = 200 nm. Size of gold 
particle = 10 nm. Asterisk=synaptic cleft. 
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3.2 Synaptic concentration of the NMDAR subunit NR2B 
I hypothesized that the synaptic concentrations of NR2B in Schaffer collateral synapses in 
CA1 are different between the learned helpless, non-learned helpless and wild-type group. As 
with the analysis of syntaxin1, I split the data file according to the region of interest and 
analyzed effects between the groups. 
3.2.1 Postsynaptic cytoplasm 
The assumption of normality was not met by the data and a suitable log (x+1) transformation 
did not lead to normality. Therefore, I opted for the non-parametric version of the one-way 
ANOVA, the Kruskal-Wallis test, to examine effects between the dependent variable density 
(µm2) and the independent variable group belonging (WT, LH, NLH). As displayed in figure 
14, a Kruskal-Wallis test revealed that the particle density (µm2) in the three groups (WT, LH, 
NLH) differed significantly in the postsynaptic cytoplasm (x
2 = 16.20, df = 2, two-tailed p < 
0.00). Determining which groups differ significantly, a Mann-Whitney U-test found that the 
density (µm2) score of particles in the learned helpless group (M= 27.33, SD = 25.04) was 
significantly higher than in the wild-type group (M= 20.95, SD = 22.50) in the postsynaptic 
cytoplasm (U = 12445.00, N1 = 174, N2 = 174, two-tailed p = 0.012). A further Mann-
Whitney U-test revealed that the density (µm2) score of particles in the non-learned helpless 
group (M= 31.46, SD = 28.19) was significantly higher than in the wild-type group (M= 
20.95, SD = 22.50) in the postsynaptic cytoplasm (U = 11635.5 N1 = 175, N2 = 174, two-tailed 
p < 0.00). Therefore, the concentration of NR2B in the postsynaptic cytoplasm is significantly 
higher in the learned helpless and non-learned helpless group compared to the wild-type 
group. Though there was no statistically significant between the groups with respect to the 
concentration of NR2B in the presynaptic cytoplasm, the mean value of NR2B concentration 
in the presynaptic cytoplasm is greatest in the learned helpless group (M = 9.72, SD = 12.96) 
compared to the non-learned helpless (M = 8.56, SD = 11.7) and the wild-type group (M = 
7.37, SD = 8.4). 
 
3.2.2 PSD 
For the dependent variable linear density (µm) and independent variable group belonging 
(WT, LH, NLH) an overall significant effect was found for the PSD. As demonstrated in 
figure 15, a Kruskal-Wallis test revealed that the linear density (µm) of particles in the three 
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groups (WT, LH, NLH) differed significantly in the PSD (x
2 = 19.88, df = 2, two-tailed p < 
0.00). A Mann-Whitney U-test found that the linear density (µm) of particles is significantly 
higher in the learned helpless (M= 11.32, SD = 11.26) than in the wild-type group (M = 7.43, 
SD = 10.71) in the PSD (U = 11739.00, N1 = 175, N2 = 179, two-tailed p < 0.00). A further 
Mann-Whitney U-test revealed that the linear density (µm) of particles is significantly higher 
in the non-learned helpless group (M= 10.40, SD = 10.88) than in the wild-type group (M = 
7.43, SD = 10.71) in the PSD (U = 12358.00, N1 = 175, N2 = 177, two-tailed p = 0.003). 
Though there was no significant effect between the groups with respect to NR2B 
concentration in the active zone, the mean value of the NR2B concentration was greatest in 
the learned helpless group (M = 5.74, SD = 9.23) compared to the non-learned helpless group 
(M = 4.84, SD = 8.47) or the wild-type group (M = 5.08, SD = 8.31). Taken together, the 
concentration of NR2B is increased in the PSD in both the learned helpless and the non-
learned helpless group compared to the wild-type group. 
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Group N Min. Max. Mean Std. Dev. 
WT 174 .00 92.62 20.95 22.50 
LH 174 .00 141.23 27.33 25.04 
NLH 175 .00 125.18 31.46 28.19 
 
 
 
 
 
Figure 14 
NR2B subunit concentration is greater in the postsynaptic cytoplasm in both the LH and NLH group 
compared to the WT group. 
 
Density of NR2B in the postsynaptic cytoplasm is significantly greater in the LH compared to the WT group (U = 
12445.00, N1 = 174, N2 = 174, two-tailed p = 0.012), and in the NLH compared to the WT group (U = 11635.5 N1 = 
175, N2 = 174, two-tailed p < 0.00). A: Semiquantative analysis of NR2B gold particle density in the WT, LH and NLH 
rats. Bars represent mean values of density +/- 2 standard errors of the mean value of the different groups. B: Electron 
micrograph from a section of a WT rat showing NR2B immunogold labeling of an asymmetric synapse in the stratum 
radiatum. C: Descriptive statistics of linear density values in the PSD of each group. D: Summary of main findings. 
WT=wild-type, LH=learned helpless, NLH=non-learned helpless, AZ=active zone, PSD=postsynaptic density, 
PostCy=postsynaptic cytoplasm, PreCy=presynaptic cytoplasm. Scale bar = 200 nm. Size of gold particle = 10 nm. 
Asterisk=synaptic cleft. 
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 Figure 15 
NR2B subunit concentration is greater in the PSD in both the LH and NLH group compared to the WT 
group 
 
 
 
 
 
 
Group N Min. Max. Mean Std. 
Dev. 
WT 175 .00 44.05 7.43 10.71 
LH 179 .00 49.98 11.32 11.26 
NLH 179 .00 43.08 10.40 10.88 
 
Linear density of NR2B in the PSD is significantly greater in the LH compared to the WT group (U = 11739.00, N1 = 
175, N2 = 179, two-tailed p < 0.00), and in the NLH compared to the WT group (U = 12358.00, N1 = 175, N2 = 177, 
two-tailed p = 0.003). A: Semiquantative analysis of NR2B gold particle density in the WT, LH and NLH rats. Bars 
represent mean value of linear density +/- 2 standard errors of the mean value of the different groups. B: Descriptive 
statistics of linear density values in the PSD of each group. C: Electron micrograph from a section of a WT rat 
showing NMDAR2B immunogold labeling of an asymmetric synapse in the stratum radiatum. D: Summary of main 
findings. WT=wild-type, LH=learned helpless, NLH=non-learned helpless, AZ=active zone, PSD=postsynaptic 
density. Scale bar = 200 nm. Size of gold particle = 10 nm. Asterisk=synaptic cleft. 
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3.3 Synaptic concentration of Arc 
I claimed that the synaptic concentrations of Arc in Schaffer collateral synapses in CA1 are 
different between the learned helpless, non-learned helpless and wild-type group. In 
accordance with prior analyses I split the data values according to the region of interest and 
then analyzed effects between the different groups. 
3.3.1 PSD 
As shown in figure 16, there exists an overall statistically significant effect of the independent 
variable group belonging (WT, LH, NLH) on the dependent variable linear density (µm) for 
the PSD as revealed by the Kruskal-Wallis test. The linear density (µm) of particles in the 
PSD significantly differs between the three groups (WT, LH, NLH) (x
2 = 6.03, df = 2, two-
tailed p = 0.049). A Mann-Whitney U-test found that the linear density (µm) of particles is 
significantly higher in the learned helpless (M= 7.06, SD = 8.00) than in the wild-type group 
(M = 5.14, SD = 6.78) (U = 13037.00, N1 = 177, N2 = 172, two-tailed p = 0.048). The 
concentration of Arc is increased in the learned-helpless compared to the wild-type group in 
the PSD. The high presence of Arc in the PSD is in accordance with other investigators (Moga 
et al., 2004). 
Mann Whitney U-tests (with a Bonferroni correction) comparing the differential location of 
Arc in the active zone and the PSD within each group revealed that Arc concentration in the 
active zone is greater than the concentration of Arc in the PSD in the wild-type (U = 
12647.00, N1 = 178, N2 = 172, two-tailed p = 0.004), as well as in the learned-helpless group 
(U = 12699.00, N1 = 178, N2 = 177, two-tailed p = 0.002). 
No significant changes of Arc concentration in the pre- or postsynaptic cytoplasm of nerve 
terminals were found between the groups. 
File names of the electron micrographs are included in appendix 5. 
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Figure 16 
Arc concentration is greater in the PSD of the LH group compared to the WT group. 
 
Group N Min. Max. Mean Std. 
Dev. 
WT 172 .00 39.67 5.14 6.78 
LH 177 .00 48.40 7.06 8.00 
NLH 178 .00 32.08 6.07 7.92 
 
Linear density of Arc in the PSD is significantly higher in the LH than in the WT group (U = 13037.00, N1 = 177, N2 = 
172, two-tailed p = 0.048). A: Semiquantative analysis of Arc gold particle density in the WT, LH and NLH rats. Bars 
represent mean value of linear density +/- 2 standard errors of the mean value of the different groups. B: Descriptive 
statistics of linear density values of each group. C: Electron micrograph from a section of a WT rat showing Arc 
immunogold labeling of an asymmetric synapse in the stratum radiatum. D: Summary of main finding. WT=wild-type, 
LH=learned helpless, NLH=non-learned helpless, AZ=active zone, PSD=postsynaptic density. Scale bar = 200 nm. Size 
of gold particle = 10 nm. Asterisk=synaptic cleft. 
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4. Discussion 
4.1 Purpose and main findings of the work 
MDD is associated with a volumetric loss of neural areas such as the PFC, the amygdala and 
the hippocampus. These neural changes may contribute to the disturbances in cognitive 
functioning and emotional stability as seen in the course of MDD. Various biological 
hypotheses of MDD focus on plastic changes in the brain as a causing, or accompanying, 
factor of this disease. Though these hypotheses comprehensively account plastic changes at 
the cellular level during MDD, the molecular correlates of these plastic changes require 
further experimental analyses. 
The objective of this study was to investigate the involvement of synaptic proteins implicated 
in synaptic plasticity in the rat learned helpless model of depression. The proteins of interest 
were syntaxin1, the NMDA receptor subunit NR2B, and Arc. I tested my claim of a difference 
in the synaptic concentrations of these proteins in Schaffer collateral synapses in CA1 
between the learned helpless, the non-learned helpless and the wild-type group. 
By comparing the learned helpless group to the wild-type group, this work revealed that the 
concentration of NR2B is greater in the postsynaptic cytoplasm and in the PSD, as well as that 
the concentration of Arc in the PSD is greater in the learned helpless group compared to the 
wild-type group. The non-learned helpless group differed from the wild-type group with 
respect to a lower concentration of syntaxin1 in the presynaptic cytoplasm and in the PSD, as 
well as an increased concentration of NR2B in the postsynaptic cytoplasm and in the PSD. 
The concentration of syntaxin1 was greater in the pre- and postsynaptic cytoplasm of the 
learned helpless group compared to the non-learned helpless group. 
 
4.2 Interpretation 
The up- and down-regulation of syntaxin1, NR2B and Arc stems from an interplay between 
synaptic scaling (homeostatic plasticity) and an alteration of synaptic strength. As described 
previously, synaptic scaling allows neurons to increase or decrease the amount of 
AMPARs/NMDARs in order to keep ongoing synaptic activity in balance. Synaptic strength 
can be altered either through changes in the presynaptic machinery releasing the 
neurotransmitter, or by changing the concentration and functions of receptors at the 
51 
 
postsynaptic plasma membrane that sense the neurotransmitter signal. Figure 17 displays a 
summary of the between-group differences in the concentration of proteins in the regions of 
interest. 
 
4.2.1 Syntaxin1 
I found a significant increase in syntaxin1 concentration in the presynaptic cytoplasm in the 
learned helpless group compared to the non-learned helpless group. Though the common 
assumption is that syntaxin1 is localized in the cell membrane of the active zone, an increased 
concentration of this protein presynaptically might indicate a potential enhancement of 
neurotransmitter release at later vesicle-membrane fusion stages (i.e a greater concentration of 
transport vesicles that deliver the neurotransmitter to the release site of the active zone). 
Because glutamate is the major excitatory neurotransmitter, one may speculate that an 
increase of syntaxin1 in the presynaptic cytoplasm prepares the presynaptic cell for an 
increased release of glutamate into the synaptic cleft. For the same token, an increased 
concentration of syntaxin1 in the presynaptic cell might indicate an increased turn-over of 
presynaptic vesicles. During the endocytosis of vesciles, the membrane might invaginate and 
detach from the plasma membrane with syntaxin1 being attached and transported back. 
The notion that syntaxin might be particularly involved in the release of glutamate is 
supported by the finding that this SNARE protein is primarily expressed in excitatory 
synapses (Koh et al., 1993). In addition, one study has found that antidepressant treatment 
disruptes the participation of syntaxin1 in the SNARE complex presynaptically leading to a 
lowered release of glutamate into the synaptic cleft (Bonanno et al., 2005). In particular, the 
interaction between syntaxin1 and Thr286 phosphorylated αCaMkinaseII that usually leads to 
an enhanced neurotransmitter release was diminished, while the interaction between syntaxin1 
and Munc-18, an interaction reducing neurotransmitter release, was enhanced. 
Besides the possible restriction of syntaxin1 being present in excitatory synapses only, Koh et 
al. (1993) also found that syntaxin1 concentration is greater in the presynaptic cytoplasm and 
is almost absent in the active zone (Koh et al., 1993). This finding is in stark contrast with the 
general notion that syntaxin1 concentration is restricted to the active zone where it regulates 
vesicle fusion (Sudhof and Rizo, 2011). 
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A lack of differences between the different groups in the concentration of syntaxin1 in the 
active zone does not imply a lack of antigen detection of the antibody because syntaxin1 was - 
without any significant differences - expressed in the active zone. It could be that syntaxin1 
might not be as easily detectable by antibodies due to the accumulation of various other 
proteins in the active zone. In addition, once at the active zone, syntaxin1 might already be 
engaged in the vesicle fusion process which might hinder the detection of the antigen by the 
antibody. 
To give an account why there was only a significant difference in the concentration of 
syntaxin1 in the cytoplasm of nerve terminals and not in the plasma membranes is 
problematic. However, research indicates that different isoforms of syntaxin (syntaxin 1-4) are 
confined to different compartments of the pre- and postsynaptic cell in the retina (Sherry et 
al., 2006). These different isoforms of syntaxin are associated with functionally different 
synapses in amacrine cells (syntaxin1) or bipolar cells (syntaxin3). In particular, Sherry et al. 
(2006) found that the isoforms of syntaxin2 and syntaxin4 are located postsynaptically, 
thereby rejecting the assumption that syntaxin2 and syntaxin4 are involved in 
neurotransmitter release at the presynaptic plasma membrane. 
I further found that the concentration of this protein is increased in the postsynaptic cytoplasm 
of the learned helpless group. The increased concentration of syntaxin1 in the postsynaptic 
cytoplasm of the learned helpless group suggests that syntaxin1 is involved in the trafficking 
of molecules to the postsynaptic plasma membrane or in the recycling of glutamate receptors. 
As it has been suggested by others (Suh et al., 2010), SNAP-23 a SNARE protein interacting 
with syntaxin1 is also found in the postsynaptic cytoplasm regulating the trafficking of 
NMDARs. A similar role of synaptic scaling could be attributed to synatxin1 where it 
regulates the trafficking and insertion of NMDARs into the postsynaptic membrane in the 
learned helpless group (as shown later, the NMDAR2B subunit is up-regulated in the PSD). In 
addition, a recent study has noted the importance of the isoform synatxin3 in postsynaptic 
regulation of AMPAR delivery to synapses during LTP, adding more evidence to syntaxin’s a 
possible involvement in the postsynaptic cell (Jurado et al., 2013). 
The findings of an increased concentration of syntaxin1 presynaptically and postsynaptically 
as described above should be regarded in connection with a higher concentration of NMDARs 
in the learned-helpless group as discussed next. 
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4.2.2 NMDAR2B subunit 
The concentration level of the NMDAR2B subunit was greater in the PSD and postsynaptic 
cytoplasm of the learned helpless group compared to the wild-type group. The increased 
concentration level of NMDARs is in line with others (Karolewicz et al., 2009) and 
underscores the importance of NMDAR antagonists such as ketamine as potential 
antidepressants (Zarate et al., 2006). A possible explanation why the concentration level of 
NR2B is increased in the PSD and the postsynaptic cytoplasm requires that the results are 
regarded in two divergent, yet interconnected, scenarios. 
First, it has been proposed that NMDARs are heavily involved in homeostatic plasticity by 
scaling the strength of incoming synaptic input up or down while preserving the relative 
weights between the inputs (Perez-Otano and Ehlers, 2005). Increasing the concentration of 
NMDARs, in this case the NR2B subunit could possibly increase the potential for synaptic 
plasticity or change. It has been suggested that MDD might be an evolutionary adaptive 
response to activate resources and make changes to the current painful situation (Nesse, 
2000). NMDARs are particularly involved in synaptic changes, or learning and memory, as 
outlined above. Therefore, learned helpless rats may display enhanced learning to make 
changes to the current depressive state. Previous research has indicated that depressed patients 
are impaired in selective attention (Lemelin et al., 1996). Impaired selective attention might 
benefit depressed patients in broadening their attention to find and adapt to changes in life. 
That MDD might be an evolutionary adaptive response is furthermore supported by a study 
showing that depressed patients are faster in making motivational responses (Chase et al., 
2010). Enhanced cognitive processing with respect to rewards might enable and motivate 
depressed patients to change current situations in life. 
Second, it is known that activation of NMDARs during LTD in the hippocampus leads to the 
endocytosis of AMPARs through a calcium influx and CN activation (Beattie et al., 2000). An 
increasing rate of AMPAR endocytosis due to the increased concentration of NMDARs 
amplifies the induction of LTD. In previous work, our group found a tendency that AMPAR 
concentration is reduced in the brains of learned helpless rats (Daaland, 2012). The findings 
above support the notion that LTD is more pronounced during MDD and - because LTP is 
impaired when glucocorticoid levels are either very low or very high (as in MDD) - that LTP 
is impaired (Kim and Diamond, 2002). Furthermore, a greater activation of NMDARs is 
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accompanied by an increased influx of Ca2+ which, when excessive, leads to neurotoxicity 
and spine retraction (Christian et al., 2011). 
As mentioned above, antidepressant treatment seems to disrupt the participation of syntaxin1 
in the SNARE complex leading to a lowered release of glutamate into the synaptic cleft 
(Bonanno et al., 2005). The increased NMDAR concentration during MDD might lead to 
glutamate excitotoxicity through an uncontrolled increase of Ca2+ postsynaptically (Duman, 
2009). Excitotoxicity is central to mood disorders, and several studies have supported the 
notion that an excess amount of extracellular glutamate is related to the pathology of MDD. 
For instance, it has been shown that stress rapidly leads to an increase of glutamate in the 
hippocampus disturbing LTP (Cazakoff and Howland, 2010). In addition, research has shown 
that extracellular glutamate concentration was increased in a learned helpless paradigm 
(Almeida et al., 2010). The high level of glutamate in the extracellular space might be 
attributed to an impaired uptake of glutamate by glial cells (Zink et al., 2010). 
It has to be taken into consideration that previous work which found a down-regulation of the 
NMDARs did not distinguish between the different subunits of the receptor (Daaland, 2012). 
The discrepancy between the present work and the latter study may be due the combinatorial 
concentration measurement of NR2A/NR2B subunits. 
 
 
4.2.3 Arc 
The concentration of the protein Arc was highly increased in the PSD of the learned helpless 
group compared to the wild-type group. It has been shown that Arc transcription depends on a 
high NMDAR/AMPAR ratio (Rao et al., 2006) and that Arc is involved in the endocytosis of 
AMPARs (Chowdhury et al., 2006). 
It is likely that an increased concentration level of NMDARs, as shown in this work, lead to 
the increase in the concentration of Arc in the PSD. It has been shown that Arc is 
predominantly localized in postsynaptic sites of recently activated synapses (Moga et al., 
2004). This makes Arc an ideal candidate as a neural marker to explore the history of neural 
activity in the brain because increased concentration of Arc mRNA is immediately observed 
upon neural activation (Guzowski et al., 1999).  It could be that recently activated synapses in 
the learned helpless group, as revealed by the immunoreactivity of Arc, underwent 
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intracellular signaling mechanisms due to glutamate excitotoxicity (increased NR2B 
concentration). 
It has also been shown that overexpression of Arc blocks the up-regulation of AMPARs, while 
Arc KO neurons exhibit an increase in AMPARs, thereby permitting the homeostatic scaling 
of synaptic strength (Shepherd et al., 2006). A recent study supports the notion that Arc KO 
neurons display a deficiency in the synaptic scaling mechanism (Beique et al., 2011). In Arc 
KO mice, a prolonged reduction of glutamate release did not lead to a homeostatic up-
regulation of AMPARs. 
Surprisingly, the present work showed that Arc is also found in the active zone which is in 
contrast to the literature claiming that Arc is absent from the presynaptic cell (Moga et al., 
2004, Shepherd and Bear, 2011). Though there was no significant difference between the 
groups, immunoreactivity for Arc was even greater in the active zone than in the PSD within 
the groups. Though there were no significant effects within or between the groups, Arc 
concentration was also present in the presynaptic cytoplasm. Because Arc mRNA is targeted 
to recently activated synaptic sites where it is translated and enhancing the synthesis of 
proteins required for synaptic plasticity (Tzingounis and Nicoll, 2006), one may speculate that 
the function of Arc in the active zone is to integrate the expression of genes that direct the 
production of presynaptic proteins. Because one way of increasing synaptic strength is in 
modulating the neurotransmitter releasing machinery, an increased concentration of Arc in the 
active zone might indicate that the concentration of other SNARE proteins besides syntaxin is 
increased. 
 
 
4.2.4 Resilient animal type 
I found additional effects particularly for the non-learned helpless group when comparing it to 
the learned helpless or wild-type group. Because non-learned helpless rats represent a resilient 
animal type towards stress, the results of this animal group are appealing with respect to the 
increasingly valuable resilience-related research. Resilience-related research informs us why 
stressful life events are controllable to some persons while the same events are uncontrollable 
to others. 
In this work, I found a significant decrease of syntaxin1 concentration in the presynaptic 
cytoplasm and in the PSD of the non-learned helpless group compared to the wild-type group. 
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Furthermore, the NR2B concentration was significantly higher in the PSD and in the 
postsynaptic cytoplasm in the non-learned helpless group in comparison to the wild-type 
group. 
Because syntaxin is instrumental in exo-endocytotic activity, I assume that a lower 
concentration in the presynaptic cell is associated with a lower release of glutamate. Given the 
lower concentration of syntaxin1 in the non-learned helpless group, the results likewise 
suggest that vesicle turn-over is decreased, possibly transporting less syntaxin away from the 
active zone. A lower level of synaptic vesicle turn-over might therefore determine a resilient 
animal type. In line with stress-resiliency, a previous study has shown that disturbing the 
participation of syntaxin in the SNARE complex leads to an antidepressant effects by 
lowering the release of glutamate into the synaptic cleft (Bonanno et al., 2005). The 
involvement of syntaxin in the endocytosis of AMPARs in the postsynaptic cell has been 
reported previously. 
The distinctions between the learned helpless and the non-learned helpless group with respect 
to the wild-type group are less clear for the concentration level of NR2B. The results showed 
that the concentration levels of NR2B in the PSD as well as in the postsynaptic cytoplasm of 
the non-learned helpless group increased in accordance with the learned-helpless group. The 
concentration of NR2B in the latter two groups were both significantly higher compared to 
the concentration in the wild-type group, but were not significantly different from each other. 
Comparing the learned helpless and the non-learned helpless group with each other revealed a 
trend in the differential concentrations. The concentration level of NR2B in the PSD of the 
learned helpless group increased slightly more than the level in the non-learned helpless 
group, while the concentration of NR2B subunit in the postsynaptic cytoplasm of the non-
learned helpless group increased slightly more than the level in the learned helpless group. 
However, this differential effect is not statistically significant and is only a tendency. 
 Nevertheless, the relationship between the learned helpless and the non-learned helpless 
group follows a linear function where a certain threshold of NMDAR concentration 
determines whether a stress response is maladaptive (learned helpless) or adaptive (non-
learned helpless). The small, though not significant difference, between the non-learned 
helpless and learned helpless group might resemble the threshold where an increasing 
glutamate excitation (increased number of NMDARs) develops into a maladaptive adaptation 
to stress causing the animal to be vulnerable to learned helpless behavior. 
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However, these speculations need to be further verified at the functional and molecular level 
by resilience-related research. 
 
 
4.3 Limitations 
4.3.1 Methodology 
It should be taken into consideration that the labeling efficacy in immunocytochemical 
procedures is influenced by the quality of the antibody, the fixation procedure, the embedding 
medium, and the incubation parameters. These factors have an impact in any experiment 
making use of immunolabeling, and very likely influenced the results of my work as well. 
When evaluating the results obtained in this work, it should further be taken into 
consideration that whether the lack of escape behavior as expressed by animals in the learned 
helpless model can unhesitatingly be applied to MDD in humans is under debate. There seems 
to be major overlap in neural activation between the LH model and MDD in humans (Pryce et 
al., 2011). However, the important question about what neural structures and functions have 
been maintained between species and what neural structures and functions underwent species 
specific adaptations is unconditionally ignored in the evaluation of animal models. 
 Figure 17 
Between-group differences 
   
A B C 
Protein concentration in the different groups. A: LH (compared to WT), B: NLH (compared to WT), C: LH 
(compared to NLH). Arrows indicate up- or downregulation of the proteins. Green=Arc, blue=NR2B, 
red=synatxin1. Background picture retrieved from http://cargocollective.com/synapses#what-is-a-synapse 
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Furthermore, with respect to MDD, clinical diagnosis is largely based on communication 
between patient and health staff. Obviously, animals lack the ability of self-reflection and 
have no means to communicate effectively with researchers. Therefore, not all clinical 
symptoms in animals can be modeled due to the reliance on verbal report in psychiatric 
diagnostics. 
The learned helpless model has strong validity criteria (Vollmayr and Henn, 2003). At the 
same time, these criteria resemble one of the greatest weaknesses of the learned helpless 
model. The face validity criterion creates a relationship between the learned helpless model 
and MDD on the basis of known signs and symptoms of MDD. A shortcoming of this 
approach is that, as the DSM-V demonstrates, some symptoms are weighted more than others 
differentiating between core and peripheral signs of MDD. According to the DSM-V, the core 
symptoms are anhedonia and depressed mood. While anhedonia, which is also a major 
symptom in schizophrenia, can be modeled in animal models, depressed mood (such as guilt 
or suicidality) cannot. The symptom of anhedonia therefore captures a great role in 
determining a depressed state in an animal neglecting the criterion of depressed mood. 
Peripheral symptoms of MDD such as psychomotor changes, fatigue or loss of energy, are the 
preferred and prominent symptoms in animal models when judging whether an animal is 
depressed i.e. learned helpless (Willner and Mitchell, 2002). 
Construct validity requires that neurobiological and psychosocial concepts of MDD are in 
alignment with the exhibited behavior of the modeled animal. This approach is clearly 
hampered by the lack of a comprehensive etiological theory on the development of MDD. It is 
far from being known how psychosocial factors (undesirable life events, chronic mild stress, 
adverse childhood experiences, and personality traits) are involved in the physiological 
processes underlying mood. In addition, there does not exist one common etiological factor 
that precedes depression, rather it is a diverse set of causes (Willner and Mitchell, 2002). 
An additional shortcoming is the discriminative effect of stress on the development of MDD. 
If very severe stress is used to induce symptoms of MDD in animals, it is possible that the 
model approximates post-traumatic stress disorder (PTSD) rather than MDD. Furthermore, 
the learned helpless model links the inability to terminate the foot shock by pressing the level 
with a depressed helpless state. However, the inability to escape or terminate the shock might 
also be related to behavioral impairments such as decreased locomotor activity or analgesia 
(Willner and Mitchell, 2002). 
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Despite the use of animal models in research of MDD, the above described limitations need to 
be taken into consideration when evaluating the results. An animal model such as the learned 
helpless model is an approximation of MDD. 
 
4.3.2 Subdivisions of the hippocampus 
 
The results obtained in this work could have been influenced by the selection of neural tissue 
from the CA1. The tissues used in this work have been dissected from the dorsal 
hippocampus. Focusing only on the ventral division of the hippocampus might have led to 
different results of the protein concentrations. The ventral hippocampus seems to be the 
subdivision which ultimately needs to be explored in research related to MDD as supported 
by the findings outlined below. 
Cognitive functioning and emotional stability are major parts of the pathology of MDD. It 
seems that these two functions of the human mind are interrelated, and also that they are 
regulated by activity in one neural area, the hippocampus (Pessoa, 2008). Despite the strong 
relationship between cognition and emotion, the hippocampus is commonly regarded as being 
purely responsible for cognitive functioning such as memory, or being solely a regulator of 
emotion. 
The hippocampus is involved in the formation of episodic memories and spatial navigation. 
However, in 1937, the hippocampus was already described by Papez as being part of an 
emotion processing system, known today as the limbic system (Papez, 1937). Given the 
different functional roles of the hippocampus it suggests itself that different regions of this 
structure may be important for different (cognitive and emotional) functions. 
Evidence for a fragmentation of the hippocampus was reviewed by Moser and Moser (1998). 
They outlined that the hippocampus contains different subdivisions because (i) the ventral and 
dorsal hippocampus have different input structures, (ii) spatial memory only appears to 
depend on the dorsal hippocampus, and (iii) stress responses and emotional behavior are only 
altered by lesions to the ventral hippocampus. In addition, the dorsal hippocampus sends 
projections mainly to areas responsible for visuospatial processing, memory processing and 
spatial exploration. In contrast, the ventral hippocampus sends projections to nuclei of the 
amygdala, the PFC, and medial zones of the hypothalamus regulating endocrine functions and 
motivated behaviors. 
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Others have found that also the induction of LTP differs between the dorsal and the ventral 
hippocampus (Segal et al., 2010) and hypothesized that the induction of LTP in the dorsal or 
the ventral hippocampus might regulate the stress responses. In normal conditions, the ability 
to evoke LTP is greater in the dorsal hippocampus. During acute stress; however, LTP is 
facilitated in the ventral hippocampus and inhibited in the dorsal region. Opposite effects 
might allow the ventral part of the hippocampus to enhance the connectivity with the 
amygdala and the PFC. 
 
4.3.3 Glial cells 
Given the current knowledge of MDD, it could be that an excess amount of extracellular 
glutamate might mirror the highly increased amount of NMDARs in the PSD and 
postsynaptic cytoplasm of the learned helpless group as shown in this work. An increased 
amount of glutamate receptors allows more Ca2+ to enter the postsynaptic cell leading to 
excitotoxicity and eventual cell death or retraction of spines. Studies suggest that the amount 
of astrocytes is reduced in MDD contributing to the pathological alterations in glutamate 
neurotransmission (Cotter et al., 2002, Ongur et al., 1998). A study has shown that glutamate 
uptake in the hippocampus is disturbed in learned helpless rats (Almeida et al., 2010) which is 
in line with a study showing that learned helpless rats have lower levels of the glutamate 
transporters GLT-1 in the hippocampus (Zink et al., 2010). A critical role in the removal of 
glutamate is performed by astrocytes containing the glial glutamate transporter (GLT-1) 
which eventually reduces the risk of excitotoxicity (Rothstein et al., 1996). It has also been 
shown that in patients suffering from MDD the level of glutamate is increased and is possibly 
related to the decreased amount of GFAP found in postmortem brains (Si et al., 2004). 
In sum, the general finding of reduced hippocampal volume might not solely be related to 
synapse or neuron loss. Though I looked at synapses in the hippocampus, investigating 
proteins such as GFAP might be promising in order to establish a link between the loss of 
glial cells and volumetric reductions of the hippocampus. Above all, glial cells might be 
heavily involved in synaptic plasticity by inducing new synapses in the CNS and maintaining 
them over time as indicated above (Pfrieger and Barres, 1997, Nedergaard et al., 2003). 
 
  
61 
 
4.3.4 Group size and outliers 
The study revealed significant effects between the learned helpless and wild-type group and 
also between the non-learned helpless and the wild-type group. However, it should be noted 
that the groups differed in the amount of animals they contained (the learned helpless and 
non-learned helpless group contained four animals each while the wild-type group contained 
two animals). 
Different group sizes affect the criterion of homogeneity of variance of the ANOVA. The 
ANOVA computes effects by comparing the variance between the groups (between group 
variance) with the variance within the groups (within group variance/error variance). A 
greater variance between the groups compared to the variances within the groups leads to 
statistically significant results. However, the greater the within variance, or error variance, 
the more likely it is to get statistically significant results by chance (Howitt and Cramer, 
2006). Since the wild-type group only contained two animals this group is more likely to 
display a greater within variance than the learned helpless or the non-learned helpless group 
that contained twice as many animals as the wild-type group. 
Because significant results could be obtained by chance by having unequal group sizes, I 
regarded the group size not as the number of animals but as the number of studied synapses. It 
could be argued that the criterion of independence might be violated. However, each synapse 
contributed to one group only once and the concentration of proteins in one synapse had no 
effect on the concentration of proteins in other synapses, i.e. they were independent. In order 
to conform both groups with respect to size, I increased the number of pictures taken of each 
animal (WT N = 180, LH N = 180, NLH N = 180). If differences in the variances occur 
nevertheless, the ANOVA is robust to differences in error and within variances when group 
sizes are equal (Howitt and Cramer, 2006). I applied the Kruskal Wallis test when the 
variances of the groups differed significantly and violated the homogeneity of variances 
criterion. 
As stated in section 3.9, I removed outliers which were further than three interquartile ranges 
(IQR) away from the end of a boxplot. I assumed these observations must have been caused 
by pure chance. Though there is no objective way to remove outliers and no real evidence that 
these are actual true values I kept outliers which were 1.5 IQRs away from a boxplot in the 
analysis. Given the very large values of outliers being further than three IQRs away from the 
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end of the boxplot, I considered them to be occurring by chance and not resembling true 
detection of antigens by the antibodies. 
 
4.4 Implications and suggestions for future work 
The results demonstrate at the molecular level that synaptic proteins such as syntaxin1, the 
NMDAR2B subunit or Arc are involved in changes of synaptic plasticity in the learned 
helpless model of depression. An altered concentration of synaptic proteins lies at the heart of 
the neuroplasticity hypothesis of MDD which implicates that malfunctioning plasticity 
mechanisms lead to a volumetric loss of the hippocampus in MDD. 
A vast amount of other synaptic proteins continue to require scientific investigation in 
unraveling their role in the pathology of MDD. A possible protein to explore is the AMPAR. A 
down-regulation of AMPARs would be in line with the results of this work and would further 
support the notion of increasing Ca2+ influx into the postsynaptic cell enhancing LTD, 
excitotoxicity and eventual cell death, i.e. volumetric decreases of the hippocampus. In fact, a 
moderate, but not significant reduction in synaptic AMPAR concentration was noted 
previously in our lab (Daaland, 2012). 
It is plausible that the reduction of neural tissue in the hippocampus during MDD might be 
mediated or even attributed to alterations in glial cells. This would support the idea of 
disturbed astrocytic clearance mechanisms of glutamate from the synaptic cleft due to the 
reduced concentration of glutamate transporters that are located in glial cells (Zink et al., 
2010). It needs to be further examined whether the neural areas displaying a volume loss are 
associated with a loss in glial cells.  
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5. Conclusion 
 
I have examined the relative concentration level of three important synaptic proteins. I found 
an increased concentration level of syntaxin1 in the pre- and postsynaptic cytoplasm, as well 
as an increased NMDAR2B subunit concentration in the postsynaptic cytoplasm and the PSD, 
and an increased concentration of Arc in the PSD of learned helpless rats. The non-learned 
helpless rats showed a significant reduction in the concentration level of syntaxin1 in the pre- 
and postsynaptic cytoplasm, as well as an increased concentration of the NR2B subunit in the 
postsynaptic cytoplasm and the PSD. The results of this work demonstrate that mechanisms of 
synaptic plasticity are altered in the learned helpless model of depression. Disturbed forms of 
synaptic plasticity might be related to the morphological and behavioral changes in the 
learned helpless model. Hence, these latter changes may be connected to the expressed 
cognitive and emotional symptoms accompanied by a volumetric decrease of the 
hippocampus as seen during MDD. 
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6. Appendix 
 
  
 Appendix 1 
Information about the experimental rats 
Animal Group Stock no. DOB LPs Time (min) 
SL3 LH 6007 11.02.2010 1 20.7 
Sl4 LH 6008 11.02.2010 0 21 
SN11 NLH 6010 12.06.2010 15 7.71 
SN12 NLH 6011 12.06.2010 14 8.7 
WT_A WT 5773    
WT_B WT 5774    
CLH_A LH 5769    
CLH_B LH 5770    
CNLH_A NLH 5771    
CNLH_B NLH 5772    
 DOB = date of birth, LP = lever press, Time = time to finish testing session, CLH = congenital learned helpless, CNLH 
= congenital non-learned helpless, WT = wild-type. 
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Appendix 3 
Composition of solutions 
Appendix 2 
Chemicals, supplier, catalogue number 
 
 
  
Product Supplier Catalogue number 
Trizma base Sigma T1503 
Sodium chloride AnalaR Normapur 27810.296 
Triton X-100 Sigma T8787 
Albumin, human serum Sigma A1653 
Polyethylene glycol Sigma P2263 
Glycine Sigma G7126 
HCI AnalaR Normapur 20252.290 
TBST 
(200ml) 
Tris solution TBST with 
50mM glycine 
(5 ml) 
TBST with 2% 
HSA (2 ml) 
TBST with 2% 
HSA and PEG 
(1 ml) 
PEG 
solution (1 
ml) 
20ml 0.05M 
Tris-HCI 
pH7.4 
 
1,211g Tris 
(Trizma Base) 
in 170 ml dH20 
18.75 mg 
glycine 
40 mg HSA 100 µl PEG 
solution 
 
5 mg PEG 
 
+ + + + + + 
180ml dH20 
with XXg 
NaCl 
(0.3% = 
0.54g, 0.4% 
= 0.79g, 
0.5% = 0.9g, 
0.6% = 
1.08g, 0.9% 
= 1.62g) 
 
Adjust HCI to 
reach p.H7.4 
and add up 
dH20 until 200 
ml 
5 ml TBST 2 ml TBST 900 µl TBST 
with 2% HSA 
1 ml TBST 
+  
0.02g 
(0.01%) or 
0.2g (0.1%) 
Triton X-
100 
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Appendix 4 
Protocol for post-embedding immunochemistry 
 
1) Place grids into a grid support plate and put on 50mM glycine in  
            TBST (Tris buffered saline with Triton X-100)                                        10min.  
      4)  Preincubate in TBST containing 2%HSA (human serum albumin)          10min.  
      5)  Incubate in primary antibody diluted in TBST containing 2% HSA    over night                                                        
6)  Rinse in TBST                                                                                       3 X short 
                                                                                                                    1 X 10min. 
                                                                                                                    3 X short 
                                                                                                                    1 X 10min. 
7)  Preincubate in TBST containing 2%HSA                                                   10min. 
8)  Incubate in secondary antibody (immunoglobulins coupled to  
     colloidal particles, 15nm). Diluted as recommended from the company 
     in TBST with 2%HSA and 0.05% PEG (polyethylenglycol)                     90min.                                                 
9)  Rinse in UF-water                                                                                   6 X short 
     Dry sections 
    10)  Incubate in 5% uranylacetate in 40% ethanol                                            90sec. 
    11)  Rinse in UF-water                                                                                   3 X short 
           Dry sections 
    12)  Incubate in lead nitrate                                                                               90sec. 
    13)  Rinse in UF-water                                                                                   3 X short  
 
           Let sections dry completely before examination in the microscope. 
 
  
 Appendix 5 
File names of electron micrographs 
Figure 12B: Syntaxin_cy_WT_5773-2_H1_23.tif 
Figure 13C: Syntaxin_PSD_WT_5773-2_H2_28.tif 
Figure 14B: NMDAR_cy_WT_5773_J1_Tv15.tif 
Figure 15B: NMDAR_PSD_WT_5773_E3_Tv41.tif 
Figure 16C: ARC_PSD_WT_5773-2_J1_26_Tv80.tif 
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